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Abstract 
The hypothalamic-pituitary-adrenal-(HPA) axis has long been closely associated with 
psychological stress-induced activation of the adrenal cortex and subsequent glucocorticoid 
production.  Another, less known peripheral limb of the psychological stress response, is the 
sympatho adrenal medullary pathway.   
We hypothesized that the sympatho-adrenal medullary system constitutes the primary response 
to acute psychological stress, with the HPA-axis functioning as a secondary response.  We tested 
our hypothesis by manipulating a model of acute mild psychological stress (restraint) by 
blocking IL-6, a valuable constituent of the sympatho-adrenal medullary system.   
Serum corticosterone concentration increased in response to stress (7 ± 3 vs. 57 ± 4 ng/ml; 
P<0.0001), a response attenuated when IL-6 was blocked (17 ± 7 ng/ml).  Stress increased 
pituitary mass only when IL-6 was blocked (38 ± 3 vs. 65 ± 6 mg; P <0.001). Stress increased 
left adrenal mass only in the presence of IL-6 (34 ± 1 vs. 73 ± 8 mg; P <0.00001). Stress did not 
influence the circulating levels of TNF-α, IL-1β or IL-6 significantly.  IL-1β and TNF-α 
concentrations in the unstressed rats were lower when IL-6 was blocked.  
We then manipulated the stress model by administering S. frutescens extract to elucidate both the 
central and peripheral effects of acute S. frutescens administration on the psychological stress 
response. 
Restraint caused decreases in hippocampal GR levels when compared to respective controls. S. 
frutescens administration and exposure to restraint synergistically decreased hippocampal 
GABAAR levels.    In addition, exposure to both stress and S. frutescens led to a noteworthy 
increase in pituitary mass (P = 0.078), as well as pituitary ACTH levels (P < 0.01).  Similarly, 
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differences in circulating ACTH levels showed an effect of stress on ACTH secretion only in the 
presence S. frutescens (P < 0.05).  Adrenal mass was significantly increased in S. frutescens-
treated animals that were also exposed to restraint (P < 0.05).  Adrenal levels of ACTH showed a 
reciprocal trend to pituitary and circulating ACTH levels.  No statistically significant differences 
were seen in adrenal IL-6 content. However, marked increases in IL-6 levels were seen at this 
level with administration of S. frutescens stress exposure and a cumulative increase seen with 
both S. frutescens-treatment and stress exposure. 
Hippocampal GABAAR, pituitary mass, pituitary ACTH and circulating ACTH levels showed a 
similar trend towards a synergistic effect of S. frutescens and restraint in activation of the 
psychological stress response, while adrenal ACTH levels showed an inverse trend.  
Hippocampal GR did not show any effect of stress or S. frutescens-treatment.  
The results from these two experiments indicate that the sympatho-adrenal medullary system 
constitutes the primary response to acute mild psychological stress and that the HPA-axis is only 
activated during an exacerbated stress response or when the sympatho-adrenal medullary 
contribution is inadequate.  Furthermore, the acute administration of S. frutescens possibly led to 
a functional shift in GABAergic function, resulting in activation of the stress response. The 
anecdotal reports of a “docile” effect of S. frutescens most likely results from activation of the 
mesolimbic dopaminergic system by the hippocampus and amygdala.  These results have 
dramatic consequence in GABA-based anxiety-treatments.  
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Opsomming 
Die hipotalamo-pituïtêre-adrenale (HPA)-as is lank bekend as ‘n primêre rolspeler in die respons 
op emosionele stres en daaropvolgende glukokortikoïed produksie.  ‘n Ander, minder bekende 
arm van die sielkundige stres respons is die simpatiese bynier-medulla-sisteem.   
Ons hipotese was dat die laasgenoemde simpatiese bynier-medulla-sisteem die primêre respons 
tot sielkundige stres behartig terwyl die HPA-as ‘n sekondêre respons bied.  Ons het ons hipotese 
getoets deur die manupilering van ‘n beproefde stres model waar ons IL-6, ‘n waardevolle 
rolspeler in die simpatiese bynier-medulla-sisteem, onderdruk het. 
In respons op stress, het serum kortikosteroon konsentrasies toegeneem slegs in die 
teenwoordigheid van IL-6 (7 ± 3 vs. 57 ± 4 ng/ml; P<0.0001), maar nie wanneer IL-6 onderdruk 
is nie (17 ± 7 ng/ml).  Stres het ‘n verhoging in hipofise massa teweeggebring slegs tydens die 
onderdrukking van IL-6 (38 ± 3 vs. 65 ± 6 mg; P <0.001).  Stres het ook linker-byniermassa 
verhoog slegs wanneer voldoende IL-6 beskikbaar was (34 ± 1 vs. 73 ± 8 mg; P <0.00001).  
Stres alleen het geen invloed gehad op serum IL-1β, IL-6 of TNF-α nie, maar die onderdrukking 
van IL-6 het wel ‘n inhiberende effek op basale IL-1β en TNF-α gehad. 
Daarna het ons weer eens die stresmodel manipuleer deur die rotte ‘n S. frutescens ekstrak te gee 
in ‘n poging om beide die sentrale en perifere effekte daarvan op die sielkundige stres respons te 
evalueer. 
Stres alleen het gelei tot ‘n afname in GR terwyl ‘n kombinasie van stres en S. frutescens 
administrasie tot ‘n afname in GABAARα1 in die hippokampus gelei het.  Hierdie kombinasie 
het ook tot ‘n merkwaardige toename in hipofise massa (P = 0.078) sowel as ACTH-inhoud van 
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die hipofise (P < 0.01) gelei. ‘n Soortgelyke patroon is waargeneem betreffende sirkulerende 
ACTH en byniermassa met P < 0.05 vir elk.  Bynier ACTH inhoud, aan die ander kant, het ‘n 
omgekeerd eweredige verhouding met ACTH in die hipofise en in sirkulasie getoon.  Bynier IL-
6 inhoud het geen statisties beduidende verskille getoon nie, maar ‘n merkwaardige verhoging is 
weereens gesien met ‘n kombinasie van stres en S. frutescens administrasie. 
Die soortgelyke tendens wat waargeneem word in GABAAR in die hippokampus, asook 
hipofise- en sirkulerende ACTH vlakke, en dui op ‘n samewerkende rol van stres en S. frutescens 
in die aktivering van die sielkundige stres respons.  GR in die hippokampus toon geen 
veranderinge nie.  Die resultate van die twee eksperimente dui op ‘n primêre rol van die 
simpatiese bynier-medulla-sisteem in die respons op ‘n akute stressor en dat die HPA-as net 
geaktiveer word tydens ‘n ooreiste stres reaksie of indien die simpatiese bynier-medulla-sisteem 
onderdruk word.  Die waargenome “verdowings”-effek van S. frutescens word moontlik deur 
aktivering van die mesolimbiese dopamien pad deur die hippokampus en amigdala bewerkstellig.  
Die resultate mag ook lei tot die heroorweging van GABA-gebaseerde angs medikasies.  
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Chapter 1 
Introduction 
An organism perceives its environment along with potential threats through integrating 
sensory signals within the central nervous system.  Potential threats (stressors) are perceived 
and evoke an intricate series of events known as the psychological stress response, leading to 
a neuroendocrine and immune reaction.  Complex cognitive processes such as learning, 
memory and emotional processing serve to either keep an organism out of harm’s way, or if 
need be, to fight off or flee from potential threats.  Ineffective resolution of the stress 
response could however be responsible for causing a number of chronic ailments such as 
anxiety, depression and post-traumatic stress disorder (PTSD) (Miller et al., 2005), as well as 
worsening other lifestyle associated diseases such as coronary heart disease (Vaccarino et al., 
2007) and other inflammatory-related ailments (Raison et al., 2006). With rising suicide 
levels, related primarily to depression and other anxiety related disorders, it is imperative to 
investigate the factors involved in the proper resolution of the stress response. 
The original concept of stress was defined as a physical strain eliciting an opposing force that 
would restore the system to an unstressed state.  Canadian endocrinologist, Hans Hugo Bruno 
Selye, redefined the concept to “a state resulting in a nonspecific response of the body to any 
demand upon it” (Selye, 1975).  The term “nonspecific” referred to a series of common 
responses which occur independently of the nature of the stressor.  Building on the work of 
Cannon in the early 1900’s who coined such phrases as “homeostasis” and the “fight or 
flight” response (Cannon, 1929), Selye proposed three universal stages of coping with a 
stressor and called it the General Adaptation Syndrome (Selye, 1976).  The first stage, 
referred to as the “alarm reaction”, was synonymous to Cannon’s “fight or flight” response 
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and associated with the sympatho-adrenal medullary system.  This stage was followed by an 
acute adaptive stage associated with resistance to the stressor, which in the face of a 
persistent stressor, eventually leads to an exhaustion stage and the death of the organism.  
During Selye’s early experiments on rats he noticed the enlargement of the adrenal glands 
after systemic injection with formalin- this eventually led to the discovery of the 
hypothalamic-pituitary-adrenocortical-(HPA) axis.  This neuroendocrine pathway, along with 
the sympatho-adrenal medullary system, has become the two signaling pathways most closely 
linked to the stress response in mammals (Lopez et al., 1999).  Both these peripheral limbs of 
the stress response ultimately end in adrenal stimulation.  Steroid secretion (glucocorticoids) 
from the adrenal cortex contributes to the resistance stage but may also contribute to the 
pathophysiology and pathogenesis of mood and anxiety disorders.  Furthermore, 
inappropriate or chronic hyper-activation of the stress system may lead to downstream 
adrenal desensitization and eventual adrenal burnout that could in turn cause a variety of 
inflammatory related diseases, including coronary heart disease and stroke, and ultimately 
premature death.  
The original dogma of non-specificity was modified by Chrousos and Gold (1992) who 
proposed that only above a certain threshold, would a stressor elicit a non-specific response.  
It was only in 1998 that Selye’s dogma of non-specificity was put to experimental testing; the 
non-specific response to any given stressor could not be confirmed by further studies (Pacak 
et al., 1998).  This however did not prevent the acceptance of the concept of a general stress 
response by scientific literature.  Within this framework of a general response, stress is 
defined as an intricate series of events, consisting of a stimulus (stressor), which precedes a 
reaction in the brain (stress perception), and activates a central nervous system (CNS) 
reaction (stress system), leading to a neuroendocrine response (Dhabhar and McEwen, 1999).   
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Studies done using immediate early gene (IEG) expression as a marker for neuronal 
activation have identified predominantly the prefrontal cortex and hippocampus, as well as 
several hypothalamic and amygdaloid nuclei, as being activated by psychological stress 
(Herman and Cullinan, 1997).  Since these structures are activated regardless of the type of 
stressor (physical e.g. swimming/foot shock, or psychological e.g. immobilisation) applied, it 
is accepted that they form part of a “general” stress response.  There is however a certain 
degree of specificity involved based on the different afferent inputs stimulating the response.  
Evidence therefore points to the presence of both a general and a stimulus-specific response, 
suggesting that the brain reacts to stress in a complex, coordinated manner and that this 
response necessitates activation of sensory, motor, autonomic, cognitive and emotional 
structures (Cullinan et al., 1995, Li et al., 1996, Campeau and Watson, 1997).  The 
psychological stress response also involves other systems beside the central nervous system 
such as the endocrine, immune and peripheral nervous systems.  It is therefore not surprising 
that links with these peripheral systems form the foundation for many of the adaptive and 
maladaptive responses of organisms to stress.   
Different types of stress have been classified based on their duration and nature.  Acute stress 
is defined as lasting no more than minutes to hours while chronic stress lasts from days or 
months, to years.  Acute stress has been implicated in an increased release of pro-
inflammatory cytokines such as interleukin-6 (IL-6), tumour necrosis factor (TNF)-α and 
interleukin-1β (IL-1β), whereas chronic stress is immunosuppressive (Elenkov and Chrousos, 
1999b, a).  Distinction between physical (local or systemic) stressors and psychological 
(progressive) stressors can also be made.  The primary disparity between physical and 
psychological stressors is the central pathways that are activated during stress signaling and 
regulation.  Physical stress signals reach the hypothalamus directly via the brainstem, while 
psychological stress signals require interpretation by higher structures of the limbic system 
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and frontal cortex.  Psychological stress, as opposed to more physiological stressors, is a bi-
dimensional concept with psychological aspects such as predictability, perception, control, 
and coping as well as physiological aspects involving different brain regions and 
neuroendocrine circuits activated by stress.  The relationships between these systems are 
complex and incompletely understood (Lopez et al., 1999), but elucidation of these 
associations and bi-directional communication is needed to increase treatment options and 
improve long-term monitoring or preventative strategies.  The aim of this thesis was to clarify 
interactions between role players in the context of stress, by manipulation of the stress 
response in an established in vivo rodent model.  However, before attempting this, the basic 
understanding of role players is required.  Therefore, in the next section, a review of the 
literature on these organs and systems is provided, in the context of acute stress. 
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Chapter 2 
Literature review 
This chapter will provide an overview of the literature pertaining to the acute stress response 
in terms of stress perception and central processing, signal transduction to effector organs, 
effector actions and role players in the regulation of this complex physiological response. 
 
2.1  Stress Perception and Processing 
Mechanisms of stress perception and processing will be discussed in terms of the limbic 
system, which consist of the amygdala, hippocampus, thalamus and hypothalamus, as well as 
neurotransmitters such as γ-aminobutyric acid (GABA) and glutamate. 
2.1.1  The Limbic System 
The stress-activated pathways responsible for the translation of stimuli into the final 
integrated response at the level of the hypothalamus are currently incompletely understood.  
It has been suggested that physiological stress is projected directly to the hypothalamus, most 
likely via the brainstem, while psychological stress or “progressive” stressors that usually 
require interpretation or modulation based on past experience may be relayed through the 
limbic-forebrain circuits (Herman and Cullinan, 1997). The limbic system forms a link 
between the higher and more complex mental activities of the cerebral cortex, and the lower 
or more basic functions such as heartbeat and breathing, which are regulated by the 
autonomic centers of the medulla.  Anatomically, the limbic areas border the innermost sides 
of the cortex and are situated around the brainstem.  The limbic system is involved in 
instinctive behavior and long-term memory.  Nerve fibers connect components of this system, 
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such as the amygdala, hippocampus, thalamus and hypothalamus to other areas in the brain 
(Fig. 2.1), predominantly the lower frontal cortex, with its functions in anticipation, reward 
and decision making (Carter, 2009).   
The thalamus is a pre-processing and communication centre from where all sensory 
information, with the exception of smell, is directed to the neocortical areas (“thinking 
brain”) via the mesolimbic pathway for processing in order to achieve conscious awareness.  
This dopaminergic pathway begins in the ventral tegmental area of the midbrain and connects 
to the limbic system via the nucleus accumbens, the amygdala, and the hippocampus as well 
as to the medial prefrontal cortex. It is known to be involved in modulating behavioral 
responses to stimuli that activate feelings of reward and motivation (Tisch et al., 2004).  The 
signal is subsequently relayed to the amygdala (“emotional brain”) for quick assessment and 
generation of emotional reactions (Kaplan et al., 2007). 
The amygdala sends impulses to the hypothalamus for activation of the sympathetic nervous 
system and subsequent HPA axis activation.  During processing of stimuli perceived to be 
potentially threatening however, the thalamus bypasses the cortex and routes the signal 
directly to the amygdala, which is the trigger point for the primitive fight-or-flight response 
(labeled the amygdala hijack) (Goleman, 1996).  The amygdala contains different regions 
called nuclei, which are distinct collections of the cell bodies (soma) from neurons that 
project signals to an array of other areas.  In the amygdala these nuclei produce different 
responses to fear, e.g. the central nucleus initiates a freezing response, while the basal nucleus 
initiates the flight response (Rasia-Filho et al., 2000).  Activation of amygdaloid nuclei are 
influenced by sex hormones and therefore differ between males and females.    Progesterone 
for example, has been shown to be a potent barbiturate-like ligand of the GABA receptor–
chloride ion channel complex, which has potent sedative and hypnotic effects (Majewska et 
al., 1986).  This sexual dimorphism could explain certain behavioral differences between 
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males and females, especially during the psychological stress response (Rasia-Filho et al., 
2000) such as the “tend-and-befriend” behavioural pattern seen in females as aposed to the 
“fight or flight” seen in males (Taylor et al., 2000).  Interestingly, classical conditioning is 
facilitated by psychological stress in males, while being impaired in females in an in vivo 
model where rats were exposed to intermittent restraint stress  (Conrad et al., 2004).   
The amygdala in turn projects signals to the hypothalamus through the bed nucleus of the 
stria terminalis (BNST), which forms part of the “extended amygdala”.  The parvocellular 
neurons of the paraventricular nucleus (PVN) in the hypothalamus represent the final 
common path for the integration of the vast array of descending circuits activated by the 
stress response in the brain (Lopez et al., 1999).  In addition, experiments performed by 
Cullinan et al. (1993) and Herman et al. (1992; 1994) also elucidated an alternative signaling 
pathway from the hippocampus, which also receives input from the amygdala directly, to the 
BNST and from there to the PVN.  The hippocampus is located along the inside of the 
parahippocampal gyrus.  Gyri are the bulges of the brain which are usually surrounded by one 
or more sulci (folds stretching towards the centre of the brain) (Carter, 2009).  The latter are 
used as orientation landmarks when investigating the brain.  The hippocampus also interlocks 
with another crease known as the dentate gyrus, which collectively forms the hippocampal-
dentate complex.  Even though this complex forms part of the cerebral cortex, it consists of 
only one to three layers of cells compared to the usual six layers of the more sophisticated 
regions of the cortex (Carter, 2009).  The hippocampus is involved in establishing memory, 
by encoding information that is consciously perceived to form memories.  The hippocampus 
also relays stored information back to the amygdala and other parts of the cortex to elicit 
confirmation or modification of the initial response to psychological stress.  It is noteworthy 
that there are more projections from the amygdala to the hippocampus than vice versa, 
indicating a flow of information from the amygdala to the hypothalamus via the 
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hippocampus.  These hippocampal inputs to the hypothalamus are primarily mediated by 
GABAergic neurons (neurons containing the neurotransmitter GABA) and are inhibitory in 
nature, suggesting a regulatory role for the hippocampus in the psychological stress response 
(Jacobson and Sapolsky, 1991).  The main hippocampal projections are from the lateral 
nucleus to the entorhinal cortex, an area of the cortex from which the hippocampus receives 
most sensory input. The hippocampus, along with being involved in spatial learning, also 
plays a vital role in psychological stress regulation by propagation of inhibitory 
neurotransmissions, thereby shifting neuronal output from sympathetic to parasympathetic.  
The best characterized inhibitory outputs from the hippocampus are conveyed through the 
ventral subiculum and the BNST-PVN (Lopez et al., 1999), the latter consisting almost 
entirely of GABAergic neurons  (Ferraguti et al., 1990).  This function will be discussed in 
more detail in section 2.3.3.   
 
 
Figure 2.1.  Relevant areas of the limbic system adapted from Essential_Survival, 2010). 
Stria terminalis 
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2.1.2  Neurotransmitters   
Neurotransmitters are chemicals that allow signals to travel between neurons and from 
neurons to other effector cells.  There are numerous types of neurotransmitters: some contain 
only acetylcholine, while another group - known as monoamines - includes dopamine, 
serotonin (5-hydroxytryptamine or 5-HT), noradrenaline and histamine.  A third group is 
comprised solely of amino acids such as glycine, aspartate, glutamate and GABA.  A 
particular neurotransmitter can either excite a receiving cell, helping to depolarize the axon 
and convey a nerve impulse, or inhibit it by down-regulating depolarization (Carter, 2009). 
GABA is the most abundant inhibitory neurotransmitter in the mammalian central nervous 
system, occurring in up to 40% of all synapses (Uhart et al., 2004).  GABA concentrations in 
the brain can be between 200 and 1000 times higher than that of monoamine or acetylcholine 
neurotransmitters, with only glutamate, the major excitatory neurotransmitter, occurring in 
higher concentrations.  Together GABA and glutamate maintain the homeostatic activity of 
neuronal transmission by balancing the inhibition and excitation of neuronal circuits.  Both 
neurotransmitters are synthesized in the brain from the Krebs cycle associated citric acid 
molecule alpha-ketoglutarate in a process known as the GABA shunt (Fig 2.2). Even though 
GABA can cross the blood brain barrier (Kuriyama and Sze, 1971), it is also synthesized 
from glutamate by an enzyme called L-glutamic acid decarboxylase (GAD).   Pyridoxal 
phosphate, a vitamin B6 derivative, is a cofactor in the synthesis of GABA from glutamate, 
explaining the incidence of convulsive seizures in patients with a vitamin B6 deficiency 
(Bayoumi et al., 1972).   
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Figure 2.2.  GABA shunt from the Krebs cycle (Olsen and DeLorey, 1999). 
GABA predominantly acts at inhibitory synapses in the substantia nigra and globus pallidus 
nuclei of the basal ganglia, the hippocampus and the hypothalamus.  It performs its inhibitory 
function by binding to specific transmembrane receptors in the plasma membrane of both the 
pre- and post-synaptic neurons, causing the opening of ion-channels.  A subsequent influx of 
negatively charged chloride ions along with an efflux of positively charged potassium ions 
result in a state of hyperpolarization of the neuronal trans-membrane potential, inhibiting the 
action potential responsible for signal transduction (Carter, 2009).  The diverse set of 
membrane bound receptors influenced by GABA can be divided into two major groups: 
ionotropic receptors that are ligand-gated ion channels (GABAAR GABACR), and 
metabotropic receptors that are G-protein coupled (GABABR) and which fulfill their function 
through second messenger systems (Bormann, 2000, Chebib and Johnston, 2000).  Work 
done by Le Novere and Changeux demonstrated that the ionotropic receptors were part of a 
nicotinic receptor superfamily that also binds nicotinic acetylcholine, as well as serotonin. 
GABAAR and GABACR can further be subdivided on account of their physiological and 
pharmacological properties as well as the fact that they form endogenous heteromeric and 
homomeric receptors respectively, consisting of five subunits each (Le Novere and 
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Changeux, 2001).  These five protein subunits are assembled around a central pore that 
comprises the actual chloride ion channel (Johnston, 2005).  GABAAR is responsible for 
most of the GABAergic signal transduction in the brain and in the context of stress, it 
functions to down-regulate the psychological stress response by inhibition of hypothalamic 
PVN and anterior pituitary neurons (Myerhofer et al., 2001).  GABAAR, however, has been 
shown to be down-regulated in response to acute immobilisation stress (Zhang et al., 1990).  
Furthermore, other types of acute psychological stress, such as social isolation, decrease the 
function of the GABAAR receptor complex (Magarinos et al., 1996).  GABAAR and 
GABABR receptors are also present in the adrenal gland, where they regulate sympathetic-
stimulated cortical steroidogenesis (Mishunina and Kononenko, 2002).  This regulatory 
function of GABA will be further discussed in section 2.3.5.  Since GABAAR is present in 
both the central and peripheral nervous system, it is a useful marker of psychological stress 
inhibition throughout the body.  In general, changes in receptor levels probably provide a 
more accurate reflection of GABA function in target tissue since GABA has a relatively short 
half-life of approximately 1.9 minutes (Enna and Snyder, 1975).  Exposure to chronic 
restraint stress led to a significant reduction in GABAAR receptor binding in the prefrontal 
cortex. Changes in specific binding of GABA to its receptors were not seen in the 
cerebellum, caudate-putamen, or hippocampus however, suggesting that the effects of 
chronic stress may be regionally specific (Gruen et al., 1995).  Increases in GABAAR levels 
observed in response to an acute forced swimming test suggest an important role for GABA 
along with its receptor in the modulation of the acute psychological stress response (Uhart et 
al., 2004). 
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2.2  Stress signal transduction 
Signal transduction of stress signals follow two major pathways in order to reach the main 
peripheral stress organ a.k.a. the adrenal gland.  As discussed above, the hypothalamic PVN 
acts as the final converging point of monosynaptic and multi-synaptic inputs from several 
areas in the brain.  This group of parvocellular neuronal cell bodies produces both hormonal 
and neuronal signals that projects to the pituitary gland and the brainstem respectively.  as a 
result,  dissociation between the ACTH-mediated neuroendocrine limb (HPA) and the non-
ACTH mediated sympathetic limb (sympatho-adrenal medullary system) of the psychological 
stress signal transduction occurs.   
2.2.1  The Hypothalamic-Pituitary-Adrenal (HPA)-axis 
The HPA-axis comprises of both neuronal circuits and endocrine components, with feed-
forward and feedback interaction between components, and therefore represents a classic 
“neuroendocrine” circuit (Ehrhart-Bornstein et al., 1991, Herman and Cullinan, 1997, Lopez 
et al., 1999).  It is at the level of hypothalamus where the stress response is transduced from a 
neuronal to an endocrine pathway.  The cells of the PVN express corticotrophin-releasing 
factor (CRH) in response to physiological stress signals, originating from the brainstem, as 
well as psychological stress signals from the thalamus (Cullinan et al., 1996).  CRH is 
released from the median eminence into the hypophyseal portal circulation to reach the 
anterior pituitary. During ACTH-mediated stress signal transduction the pituitary gland or 
“master gland” is stimulated by CRH to secrete adrenocorticotrophic hormone (ACTH) from 
its pro-opiomelanocortin (POMC) producing cells (corticotrophs) through POMC precursor 
molecule processing in the anterior pituitary (Feldman et al., 1995).  ACTH travels through 
the systemic circulation and binds to its receptors in the adrenal cortex.  These receptors, 
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upon ligand binding, undergo conformational changes that stimulate the enzyme adenylyl 
cyclase, leading to an increase in intracellular cAMP and subsequent activation of protein 
kinase A. This ultimately results in stimulation of steroidogenesis in the zona fasciculata of 
the adrenal cortex.  As a result of acutely increased steroidogenesis the adrenal gland 
undergoes certain morphological changes, such as cellular hypertrophy, hyperplasia and 
decreased number of liposomes while chronically augmented steroidogenesis could result in 
hypervascularisation, along with increased density of mitochondria and smooth endoplasmic 
reticulum, (von Euler, 1967).  Liposomes store cholesterol, the substrate of glucocorticoid 
biosynthesis (Bornstein et al., 1992, Nussdorfer and Gottardo, 1998).  Glucocorticoid 
secretion from the adrenal cortex is the final product of the psychological stress response 
(discussed in further detail at the end of the section).   
2.2.2  The Sympatho-adrenal medullary system 
The sympatho-adrenal medullary system, with the brain stem and hypothalamus as central 
components, relies on the transduction of a signal from the central to the sympathetic nervous 
system.  The majority of these sympathetic nerve fibers have been demonstrated to be 
cholinergic preganglionic sympathetic fibers arising predominantly from the third thoracic 
and second limbic vertebra/regions of the spinal cord (Hollinshead, 1937).  Relatively more 
modern retrograde fiber tracing techniques verified these claims but also produced 
morphological evidence of both, preganglionic and postganglionic, sympathetic and 
parasympathetic, innervations along with an afferent baroreceptor component innervating the 
adrenal glands (Kesse et al., 1988, Afework, 1989, Coupland et al., 1989).  The majority of 
nerves penetrate the adrenal capsule where they branch to form an extensive subcapsular 
network.  The possibility of an integrated neural regulation of both the cortex and medulla 
has led to a unified approach to understanding adrenal function.  The cells of the adrenal 
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gland receive both extrinsic as well as intrinsic innervations, the latter consisting of ganglion 
cells scattered throughout the cortex and medulla (Coupland, 1965).  Ultrastructural studies 
performed in the nineteen seventies revealed the existence of synaptic terminals adjacent to 
cortical cells (Unsicker, 1971, Robinson et al., 1977).  The ganglion cells are said to originate 
from sympathetic neurons that differentiated from the neuronal crest cells which migrated 
into the cortical zonas (Pelto-Huikko et al., 1985). Even though traditionally only the adrenal 
medulla was associated with innervation, evidence now suggests the presence of a smaller 
quantity of branched neural fibers also distributed into the cortex (Parker et al., 1993).  
Signals travel through the splanchnic nerves to the adrenal medullae (Goldstein, 1995), and 
are mainly cholinergic and peptidergic, storing the catecholamines dopamine, epinephrine 
and nor-epinephrine along with a variety of neuropeptides such as neuropeptide Y (NPY) and 
CRH.  Catecholamine secretion is mediated by nicotinic cholinergic receptors located in the 
membranes of medullary chromaffin cells (Parker et al., 1993).  Intra-adrenal communication 
between the two ontogenetically different regions (regions originating from different 
embryonic germ cell lines) of the adrenal gland, are mediated by a variety of secretory 
products.  In situ and in vitro studies have shown epinephrine and nor-epinephrine, the main 
adrenomedullary secretory products, to stimulate adrenocortical function by augmentation of 
the transcriptional activity of several steroidogenic factors and enzymes (Ehrhart-Bornstein et 
al., 1991, Guse-Behling et al., 1992).  Probably the most significant splanchnic contribution 
to adrenocortical steroidogenesis is mediated through these catecholamines and other 
neuropeptides released from adrenomedullary chromaffin cells in large amounts.  Previous 
studies performed by our group also demonstrated the IL-6 dependent nature of psychological 
stress-associated corticosterone release.  This finding is supported by literature where mRNA 
analysis of IL-6 and IL-6 receptor gene expression indicated a para- and/or autocrine function 
of IL-6 in adrenal medulla regulation (Gadient et al., 1995).  It is therefore plausible to 
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assume that IL-6 plays a role in the adrenal activation by sympathetic nerves.  This role of IL-
6 will be further discussed in section 2.3.6. 
The influence of the sympatho-adrenomedullary system on the psychological stress response 
can also be demonstrated by its ability to increase adrenocortical sensitivity to ACTH.  
Edwards et al., 1998 showed that stimulation of splanchnic nerves resulted in enhanced 
production of glucocorticoids in response to a standardized ACTH stimulus, while splanchnic 
lesions decreased adrenocortical sensitivity to ACTH.  Studies also showed that perfused pig 
adrenal glands with intact splanchnic innervations could elicit steroidogenesis upon electrical 
activation in the absence of pituitary-derived ACTH (Ehrhart-Bornstein et al., 1991, Ehrhart-
Bornstein et al., 1994, Ehrhart-Bornstein et al., 1995).  Furthermore, the sympatho-
adrenomedullary system seems to contribute to compensatory growth signals in remaining 
adrenal glands after unilateral adrenalectomy (Dallman et al., 1976).  The adrenal gland can 
therefore be described as a modified sympathetic splanchnic ganglion surrounded by a 
steroidogenic endocrine gland, and appears to form another link between nerve and hormone 
systems in the integrated neuro-endocrine stress response. 
Morphologic characteristics of the adrenal gland provide clues as to how the medullary 
secretions reach cortical cells.  Contrary to popular belief the cortex and medulla are not 
clearly separated but rather intertwined with adrenomedullary chromaffin cells found in all 
three cortical zones and cells from all these zones found within the medulla (Gallo-Payet et 
al., 1987).  Chromaffin cells in the cortex either form ray-like structures, radiating outwards, 
or small chromaffin islets, while some are simply dispersed throughout the zona fasciculata 
and reticularis, surrounded by steroid-producing cells.  In the capsular region of the zona 
glomerulosa, chromaffin cells often form subcapsular nests (Fortak and Kmiec, 1968).  On 
the other hand, islets of cortical cells are found within and bordering adrenomedullary 
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chromaffin tissue (Bornstein et al., 1994).  Ultrastructural analysis of contact areas between 
cortical and medullary cells throughout the different cortical zones show no separation by 
connective tissue or interstitial fluid and allow for extensive paracrine interaction (Hoheisel et 
al., 1998).  Studies performed in cat adrenals demonstrated additional transport mechanisms 
of adrenomedullary secretory products through interstitial fluid and lymphatics.  Except for 
catecholamines, which enter the blood vessels directly, other larger secretory molecules such 
as neuropeptides cross into and out of the lymph to reach the adrenocortical cells.  
Catecholamines, due to its swift entry into circulation, can only influence cortical cells in 
direct contact with the catecholamine-producing chromaffin cells to secrete corticosterone 
(Carmichael et al., 1990).   
Once in circulation, catecholamines prepare the body for the fight or flight response by 
binding to β-adrenergic receptors on a vast array of target tissues.  Some of these preparations 
include redirecting blood flow from organs to skeletal muscle, increasing heart rate, dilating 
pupils, along with numerous other effects that serve to improve the organism’s chances of 
surviving stressful events (Sherwood et al., 2004). 
The function of both above mentioned systems are crucial for an integrative stress response 
and their regulation is therefore a complex, adaptive process characterized by compensation 
by one pathway in the event of alternative pathway inhibition.  Nevertheless, upon activation, 
both pathways eventually lead to downstream glucocorticoid production and release from the 
adrenal cortex.   
2.2.3  Glucocorticoids  
Glucocorticoids are steroid hormones that derive their name from their primary function, 
which is to increase blood glucose levels, as well as their site of production, i.e. the adrenal 
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cortex.  The predominant glucocorticoid in humans is cortisol, while corticosterone is most 
abundant in rodents.  An average person secretes between 10 to 20 mg cortisol per day during 
his/her circadian rhythm, which is also under the control of pituitary ACTH (Katzung, 2004, 
Goodman et al., 2006).  Under normal circumstances, 90% of plasma cortisol is bound to 
circulatory proteins called corticosteroid binding globulin (CBG) while the remaining 10% is 
either free or loosely bound to albumin, and thus accessible for glucocorticoid receptor 
binding.   
Glucocorticoids perform a wide variety of functions through glucocorticoid receptor binding, 
including metabolic (glucogenolysis and gluconeogenesis) as well as immune (suppression of 
cell-mediated and humoral immunity) regulation.  The majority of these functions are 
achieved by genomic regulation, such as limiting the number of circulating neutrophils and 
macrophages by suppressing the production of pro-inflammatory cytokines.  Glucocorticoids 
have been shown to induce apoptosis in lymphocytes (Seki et al., 1998) and eosinophils 
(Schleimer and Bochner, 1994), and up-regulate phagocyte capacity to clear apoptotic 
neutrophils (Nittoh et al., 1998).  Another contribution of glucocorticoids to inflammatory 
resolution occurs through non-genomic regulation and involves a biosynthetic shift from 
inflammatory arachidonic acid toward anti-inflammatory endocannibinoids (Malcher-Lopes 
et al., 2008).  Glucocorticoids are also vital in the regulation of the reproductive and central 
nervous system (Lu et al., 2004). This aspect was discussed already in terms of 
steroidogenesis in section 2.3.2. Maintenance of elevated plasma glucocorticoid levels during 
times of acute and chronic psychological stress requires a shift in substrate allocation away 
from anabolic steroids, such as testosterone, growth hormone (GH) and estrogen, toward 
glucocorticoid synthesis, which results in an inevitable reduction in other adrenal steroids.  
The pathways involved with the steroidogenic shift can be attributed to increases in pro-
inflammatory mediators activated by the psychological stress response, particularly cytokines 
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produced within the adrenal gland.  It is also speculated that activated lymphocytes within the 
adrenal medulla could trigger a major histocompatibility complex (MHC) class II-mediated 
cell death, class II being the dominant MHC molecule expressed on adrenomedullary 
androgen producing cells (Marx et al., 1998).  This shift, however, is crucial for survival 
when threatened by stress or illness.  The stress regulatory role of glucocorticoids will be 
discussed in more detail in section 2.3.   
2.3  Stress regulation 
Both activation and termination of the adrenocortical stress response are vital to the 
adaptation and survival of the organism.  It is known that chronic stress that coincides with 
elevated corticosterone levels is connected to various harmful effects such as adrenal burnout, 
which could lead to inflammatory related ailments such as diabetes and coronary heart 
disease.  Different role players in the regulation of the response to stress will be discussed in 
the next section. 
2.3.1  Glucocorticoid-associated systems 
2.3.1.1.  Traditional glucocorticoid negative feedback loop 
Circulating glucocorticoids inhibit their own secretion through three mechanisms, namely a 
rate-sensitive fast feedback, an intermediate feedback and a delayed feedback (Keller-Wood 
and Dallman, 1984).  The fast feedback occurs within minutes and is based on the rate of 
increase in glucocorticoid levels rather than the total systemic level.  This mechanism is 
achieved in part by the binding of glucocorticoids to their specific receptors (glucocorticoid 
receptors) in the hypothalamus, which inhibits CRH secretion, while in other limbic 
structures such as the hippocampus, it down-regulates excitatory glutamatergic signals and 
increases inhibitory GABAergic signal transmission. Intermediate and delayed feedback 
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occurs over the course of hours to days and is based on the transcriptional suppression of 
CRH and POMC gene expression by translocated glucocorticoid receptor (GR) complexes.  
Even though a portion of the functions performed by glucocorticoids are mediated through G-
coupled proteins, the predominant functional feedback route followed by glucocorticoids, 
involve GR.  
2.3.1.2  Glucocorticoid Receptors 
According to both functional and biochemical traits, two types of corticosteroid receptors are 
distinguished, and both are also present in the brain (de Kloet et al., 1998b).  Type I or 
mineralocorticoid receptor (MR) has high affinity for cortisol/corticosterone and is primarily 
found in the hippocampus and other limbic areas, whereas Type II, or low affinity 
glucocorticoid receptor (GR), is more widely distributed across the regions of the brain (Zhe 
et al., 2008).  In the rest of the body, MR and GR are expressed in almost every cell in the 
body and regulates genes controlling the development, metabolism, and immune response 
(Lu et al., 2006). 
These receptors mediate a variety of effects on neuronal excitability, neurochemistry and 
neuroplasticity (McEwen, 1999).  MR, being described as a “high-affinity, low-capacity 
glucocorticoid receptor system”, is said to offer tonic inhibition of the axis during the nadir of 
the circadian rhythm (Funder, 1986, de Kloet et al., 1998b, Lopez et al., 1999).  However, 
during the psychological stress response cortisol levels increase dramatically, leaving the MR 
saturated and the GR, being described as a “low-affinity, high-capacity” receptor, 
maintaining or facilitating the return to homeostasis. 
In the context of stress regulation, MR has also been illustrated in the kidney where, due to 
the presence of an enzyme known as 11-beta hydroxysteroid dehydrogenase (11β-HSD), it 
also has affinity for aldosterone.  11β-HSD is part of an enzyme family which catalyze the 
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conversion of inert 11 keto-products (cortisone) to active cortisol, and vice versa.  In the 
kidney, it inactivates cortisol to cortisone, enabling aldosterone to bind to the MR.  11β-HSD 
is also found in the liver, adipose tissue and central nervous system where it contributes to 
glucocorticoid regulation (Seckl and Walker, 2001).  Although the exact effect of stress on 
the GR is controversial, previous studies conducted by our group as well as other groups 
showed a marked reduction of the GR in response to acute and repeated psychological stress 
in both the brain and peripheral tissues such as the liver (Omrani et al., 1980, Sapolsky et al., 
1984, Smith et al., 2007). 
2.3.1.3.  Stress and inflammation 
Acute psychological stress is associated with an increase in pro-inflammatory cytokines such 
as IL-1β, IL-6 and TNF-α (Maes et al., 1998, Smith et al., 2007) at different time points.  
These increases in pro-inflammatory cytokine levels are necessary for proper HPA-axis 
function on multiple levels.  For example, IL-6 have been shown to contribute to the 
psychological stress-induced corticosterone release directly by stimulation of the adrenal 
gland (Path et al., 1997, Franchimont et al., 2000b), or upstream via activation of the HPA-
axis (Mastorakos et al., 1993, Zhou et al., 1993).  IL-6 is also associated with greater 
bioavailability of corticosterone through the inhibition of cortisol binding globulin, thereby 
enhancing the stress response (Bartalena et al., 1993).  Inflammatory cytokines such as IL-6 
thus plays a pivotal role in strengthening the response to psychological stress.   
One of the primary functions of glucocorticoids could be described as a mediator of 
inflammatory resolution; with binding of glucocorticoids to their specific cytoplasmic GR 
leads to the translocation of the GR to the nucleus where it acts as ligand-induced 
transcription factor (Caamano et al., 2001).  GR either binds directly to cognate response 
elements in target gene promoters, thereby regulating gene expression, or obstructs other 
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signaling pathways such as those involving nuclear factor κβ (NF-κβ), an inducible 
transcription factor complex that regulates the expression of a range of genes involved in 
inflammatory immune responses (Smets et al., 1999). 
In contrast, in vivo studies also illustrated that a GR antagonist could not block the inhibition 
of CRH-induced ACTH secretion after an intravenous glucocorticoid injection (Hinz and 
Hirschelmann, 2000).  The same measure of inhibitory effects was seen even after the 
blocking of gene transcription and protein synthesis in vitro (Dayanithi and Antoni, 1989).  
This points to the alternative non-genomic nature of the GR.  Recent findings suggested that 
glucocorticoids induce the synthesis of arachidonic acid-derived endocannibinoids in the 
neuroendocrine cells of the hypothalamus.  This lowers the availability of arachidonic acid 
for pro-inflammatory prostaglandin synthesis (Malcher-Lopes et al., 2008).  These non-
genomic regulatory actions of glucocorticoids entail inhibition of various pathways by 
intracellular and/or membrane-bound receptors and are especially active in neurons of the 
central nervous system.  The reduction in the inflammatory input marks the resolution of the 
psychological stress response and constitutes another more indirect contribution of 
glucocorticoids to stress termination as seen in Fig 2.3. 
2.3.1.4.  Neuronal regulation by glucocorticoids   
In addition to the immune-regulatory functions of glucocorticoids in stress regulation, the 
limbic circuits of the amygdala and hippocampus, along with their neurotransmitters, are also 
regulated through non-genomic glucocorticoid action.  Di et al. (2003) recently proposed that 
glucocorticoids elicit a rapid suppression of excitatory glutamatergic synaptic inputs while 
having an opposite effect on inhibitory GABAergic neuronal inputs to the neuroendocrine 
cells of the PVN in the hypothalamus.  Glucocorticoids are therefore an important role player 
in the maintenance of a normal excitatory/inhibitory balance in the central nervous system.  
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This regulation is said to function through activation of a postsynaptic, membrane-associated 
receptor and the G-protein-dependent synthesis of retrograde endocannibinoid messengers 
(Di et al., 2003, Di et al., 2005).  The pathways involved in this glucocorticoid-mediated 
endocannibinoid synthesis necessary for the opposing regulation of GABA and glutamate, are 
the GαS G-protein subunit and the cAMP-dependent protein kinase (PKA) pathway (Malcher-
Lopes et al., 2008).  In a study by Di et al. performed in 2003, they determined that 
glucocorticoids activate different G-protein signaling pathways in parallel, via the GαS and 
Gβγ subunits, and subsequent production of endocannibinoids and nitric oxide (NO) 
respectively.  These retrograde messengers act in a synapse-specific manner to suppress 
excitatory synaptic inputs, as seen in the case of endocannibinoid-binding to its pre-synaptic 
receptor, and facilitate inhibitory synaptic inputs, in the case of NO (Di and Tasker, 2008).  
Therefore, glucocorticoid-induced shift in neuronal activity from excitatory (sympathetic) 
towards inhibitory (parasympathetic) signaling in, for example the hippocampus, could 
attenuate the psychological stress response at perceptional level and play a pivotal role in 
stress regulation (Fig. 2.3). 
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Figure 2.3.  Glucocorticoid receptor mediated contribution to resolution of the psychological stress 
response can be divided into non-genomic and genomic functions.  The non-genomic functions are 
mediated through membrane bound glucocorticoid receptors (mbGR) which consist of Gβγ and GαS 
proteins that activates neuronal nitric oxide synthase (nNOS) and the cAMP-PKA pathways to 
produce NO and cannabinoid receptor 1 (CBr1) respectively.  The increased intracellular NO 
concentrations within neurons causes increased GABA release while binding of endocannabinoids 
(EC) to CBr1 upregulates glutamatergic (Glu) neurotransmission.  The increased GABAergic and 
decreased glutaminiergic neurostransmission increases the inhibitory input to the psychological stress 
response.  The genomic functions are mediated through cytosolic glucocorticoid receptors (cytGR) 
which activates inhibitor of kappaB (IκB), downregulating nuclear factor-κB (NF-κB) which is 
responsible for stimulating the transcription of inflammatory cytokines.  The decreased cytokine levels 
signal the resolution of inflammation which is also a signal for the down-regulation of the 
psychological stress response. 
2.3.2  Testosterone 
Testosterone is a steroid hormone and the most important androgen secreted into the 
bloodstream.  In mammals testosterone is primarily secreted by Leydig cells in the testes of 
males and the ovaries of females, while small amounts are secreted by the adrenal cortex.  
Testosterone is also the principle male sex hormone and a powerful anabolic steroid and is 
regulated by the Hypothalamic-Pituitary-Gonadal (HPG) axis (Selye, 1946).  Gonadotropin-
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releasing hormone (GnRH) is secreted by the hypothalamus which in turn stimulates the 
pituitary gland to release follicle stimulating hormone (FSH) and luteinising hormone (LH). 
These latter two hormones stimulate the testis to synthesize testosterone.  Increasing levels of 
testosterone act on the hypothalamus and pituitary through a negative feedback loop to inhibit 
the release of GnRH and FSH/LH respectively (Swerdloff et al., 1992, Payne and 
O'Shaughnessy, 1996).  The reproductive system undergoes significant inhibition during the 
adaptive response to psychological stress (Johnson et al., 1992).  Hans Selye proposed that 
chronic stress causes an exacerbated HPA axis response, while inhibiting the HPG-axis 
(Selye, 1939).  Rat studies on the chronic response to immobilisation, immersion in cold 
water, and electrical foot shock have shown decreases in serum LH and testosterone 28 days 
after initiation of the stress protocols (Sapolsky and Krey, 1988, Norman and Smith, 1992), 
while human studies show marked negative effects of stress on various parameters of semen 
quality such as sperm concentration, motility and morphology (Moghissi and Wallach, 1983, 
Bents, 1985, Giblin et al., 1988).  These changes were attributed to lower levels of LH and 
testosterone (Tilbrook et al., 1999).  11 beta-hydroxy-steroid dehydrogenase (11β-HSD) in 
Leydig cells oxidatively inactivates corticosterone, decreasing its concentration, as mentioned 
earlier, thereby protecting cells against the suppressive effect of glucocorticoids on 
testosterone production (Monder et al., 1994, Gao et al., 1996).  Even though numerous 
studies has been done in this field using different models of stress, few of them actually show 
correlations between increases in corticosterone and testosterone suppression, nor can it be 
confirmed that acute stress negatively affects sexual behavior (Retana-Marquez et al., 2003).  
On the other hand, chronic stress have been implicated in increased plasma corticosterone 
levels in rats and hamsters, and increased cortisol levels in humans, while inhibiting the HPG 
axis (Collu et al., 1984, Remes et al., 1985, Gonzalez-Quijano et al., 1991).  Whether or not 
testosterone synthesis is significantly influenced by acute activation of the sympatho-adrenal 
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medullary system is unclear.  The elucidation of this matter is necessary in order to inform on 
possible side-effects of stress, which should be considered in development of anti-anxiety 
remedies.  
2.3.3  Hippocampal regulation 
Higher limbic structures such as the hippocampus, and in particular the GABAergic neuronal 
connections of the BNST between the hippocampus and the hypothalamic CRH neurons, also 
play a role in the regulation of the HPA-axis (Herman et al., 1992, Cullinan et al., 1993, 
Herman et al., 1994, Herman et al., 1996).  Studies using gross hippocampal lesions along 
this tract, as well as hippocampalectomies, have shown an up-regulation of CRH mRNA 
during increased circulating corticosterone and ACTH levels (Herman et al., 1989).  It 
appears that the results of these studies point to a decreased negative feedback as well as an 
increased basal drive.  Evidence arising from these studies also point to a role for the 
hippocampus in maintaining the basal tone of the HPA-axis.  The tonic inhibition of ACTH 
secretion from pro-opiomelanocytes in the hypothalamic PVN by the hippocampus is likely 
achieved through the binding of corticosterone to hippocampal GR (Herman et al., 1989) as 
well as the indirect activation of inhibitory GABAergic neurons, mainly in the hippocampal 
CA1-3 regions (Jacobson and Sapolsky, 1991), by elevated corticosterone levels in response 
to stress.  This is likely mediated via a negative feedback by glucocorticoid binding to G-
coupled proteins located in the hippocampus and subsequent inhibitory neuronal inputs to the 
hypothalamic PVN (Herman et al., 1989).  Collectively these studies suggest a major role for 
the hippocampus in the modulation of basal as well as stress associated levels of downstream 
CRH and ACTH by reciprocal input to the thalamus and PVN of the hypothalamus. 
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2.3.4  GABAergic regulation 
Of similar importance is the biochemical constituents involved in the circuitry between 
limbic and peripheral components, and their role in the regulation and termination of the 
stress response.  Inhibitory hyper-polarization of central neurons prevents hyper-excitation 
and provides suitable down-regulation after stressful experiences.  This balance between 
excitatory glutamate and inhibitory GABA is crucial for the maintenance of homeostasis and 
dysfunction or deficiency in either could lead to severely decreased quality of life and even 
premature death.  Although GABAergic function in the cerebral cortex does not seem to be 
affected by an acute pain stress (Sherman and Gubhart, 1974), striatal pathways (the main 
neuronal pathways running from the forebrain to the basal ganglia) are very sensitive to acute 
stress experiences (Losada, 1988).  A study where GABA, along with its synthesising and 
degradation enzyme activity were measured, showed a markedly decreased GABA turnover 
in the corpus striatum directly after one hour of immobilisation stress and an increase to 
levels above baseline three hours after cessation of stress exposure in a super-compensatory 
fashion (Yoneda et al., 1983, Losada, 1988).  Experimental animals displayed signs of hyper-
excitability at time points during a depressed GABA activity phase, explaining the correlation 
between GABAergic activation and docile behavioral patterns.  GABA contributes to stress 
resolution by decreasing neuronal firing, thereby blocking CRH-release into portal circulation 
(de Kloet et al., 1998a), specifically by inhibiting acetylcholine and serotonin-induced CRH 
secretion (Hillhouse and Milton, 1989).  This stems the liberation of ACTH from the anterior 
pituitary, causing an interruption in the HPA cascade and thus resulting in stress resolution.  
GABA also exerts a regulatory effect on the main peripheral effector organ of the 
psychological stress response namely the adrenal gland.  Studies performed by Kataoka et al. 
(1984) showed that cultures of adrenomedullary chromaffin cells synthesize, store, release 
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and activate GABA.  The GABA receptor complexes located on these cells are functionally 
coupled to nicotinic receptors and are involved in the modulation of cholinergic-induced 
catecholamine release.  Aside from catecholamine release, activation of nicotinic receptors 
also stimulates the release of GABA from chromaffin cells which is speculated to in turn 
reduce nicotine-elicited catecholamine secretion by lowering the trans-synaptic evoked 
increase in excitability in adrenal medullary cells.  This is accomplished by inhibition of 
adenylyl cyclase activity, the opening of G-protein-activated K+ channels and inhibition of 
voltage-gated Ca2+ currents (Bowery et al., 2002, Metzeler et al., 2004).  Intracellular Ca2+ 
levels are known to play a vital part in the regulation of adrenocortical function (Foster et al., 
1997).  Recent studies also demonstrate the presence of GABA receptors on steroid-
producing adrenocortical cells, suggesting both a paracrine and autocrine function of GABA 
in modulating steroidogenesis in rat cortical cells (Chessler et al., 2002, Gamel-Didelon et 
al., 2003, Metzeler et al., 2004). 
2.3.5  Brain-Derived Neurotrophic Factor 
Acute as well as prolonged exposure to psychological stress and the primary stress hormone, 
corticosterone, is reported to decrease the expression of brain derived neurotrophic factor 
(BDNF) in the CA1 region of the hippocampus (Schaaf et al., 1998).  BDNF is a growth 
factor of the neurotrophin family which is secreted in the central and peripheral nervous 
system as well as in the kidneys and testis (Binder and Scharfman, 2004).  Even though the 
majority of central neurogenesis takes place prenatally, certain areas of the brain maintain the 
capacity to grow new neurons from neural progenitor cells.  This process is modulated by 
neurotrophins, especially BDNF, which supports the survival of living neurons as well as 
spurring the proliferation and differentiation of new neurons and synapses (Acheson et al., 
1995, Huang et al., 2005).  These functions are achieved by the binding of BDNF to at least 
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two types of receptors on the surface of BDNF-responsive cells in target tissues nl., TrkB 
(pronounced “Track B”), a tyrosine receptor kinase, is capable of phosphorylating 
intracellular tyrosine molecules, activating cell signaling, and p75, a low-affinity nerve 
growth factor receptor (LNGFR) (Patapoutian and Reichardt, 2001).  In the brain, BDNF is 
most active in the prefrontal cortex and the hippocampus, two central areas prominently 
activated by psychological stress.   The down-regulation of BDNF by adrenocortical 
corticosterone secretion after exposure to chronic immobilisation may explain the occurrence 
of hippocampal atrophy (Schaaf et al., 1998).  In vivo studies have also shown hippocampal 
atrophy in rats bred heterozygously for BDNF (in order to reduce the expression of BDNF), 
while BDNF knockout mice had severe repercussions including cerebellar abnormalities such 
as increased sympathetic innervations, and postnatal lethality (Blake et al., 2003).  Vollmayr 
et al. (2000) demonstrated that rats exposed to either single or repeated exposures to 
immobilisation showed markedly lower BDNF mRNA levels in the hippocampal formation. 
The apparent stress-induced atrophy as well as the decreases in circulating BDNF levels 
suggests that BDNF may be a noteworthy marker of the psychological stress response and its 
effects, and that it could be exploited as a predictor of prognosis in acute as well as chronic 
stress related diseases.   
2.3.6  IL-6 and other pro-inflammatory cytokines 
In the 30 years since work in the field of psychoneuroimmunology began, studies have 
convincingly established that stressful experiences alter features of the immune response 
(Segerstrom and Miller, 2004).  It is well known that a variety of stress-related ailments, such 
as coronary heart disease, have a strong inflammatory component.  Certain immune inputs, 
mediated through cytokines, also regulate the secretion of corticosterone.  The most 
prominent cytokines released in response to psychological stress are IL-1β, IL-6 and TNF-α 
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which are secreted in concert by immune cells located within the inner adrenal cortex as well 
as adrenocortical cells themselves (Gonzalez-Hernandez et al., 1996, Path et al., 1997).  
Despite the presence of high levels of locally produced glucocorticoids, these above 
mentioned cells have the ability to maintain synthesis and secretion of pro-inflammatory 
agents.  This phenomenon can most likely be explained by the presence of migration 
inhibitory factor, which overrides the anti-inflammatory effects of the glucocorticoids 
(Bacher et al., 1997).  Cytokines exert stimulatory and/or inhibitory effects on adrenal 
function and their expression vary between species.  In rats, cytokines originating from the 
medulla are predominantly illustrated in the cortical zona glomerulosa where it stimulates 
corticosterone producing cells, while in humans the main site of production is the inner zona 
reticularis (Judd, 1998).   
From the literature consulted, IL-6 seems to exert both pro- and anti-inflammatory effects.  
The primary functions of this cytokine are pro-inflammatory, for example stimulation of T 
cell proliferation, and prompting secretion of other pro-inflammatory cytokines and acute 
phase proteins (Mendel et al., 1998, Marby et al., 2001, Steptoe et al., 2001, Black and 
Garbutt, 2002, Pedersen and Fischer, 2007, Filiopoulos and Vlassopoulos, 2009).    However, 
IL-6 is also a potent activator of the HPA-axis by neuronal stimulation of the hypothalamic 
PVN and pituitary to release of CRH and ACTH respectively, leading to the release of 
glucocorticoids, a very powerful anti-inflammatory hormone (Lyson and McCann, 1991, 
Spinedi et al., 1992, Jankord et al., 2007).  IL-6 has also been proven to inhibit cortisol 
binding globulin synthesis, thereby increasing the bioavailability of cortisol (Bartalena et al., 
1993).  Lastly, IL-6 performs an indirect anti-inflammatory function by down-regulating 
stress-induced TNF-α through a negative feedback loop (Aderka et al., 1989, Schindler et al., 
1990, Nukina et al., 1998b).   
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In vivo studies reported a positive correlation between increases in steroidogenic-stimulators 
such as ACTH and IL-6 in circulation (Lyson and McCann, 1991, Matta et al., 1992).  
However, it is not yet known whether or not this correlation follows through to tissue level.  
Cytokines can influence adrenocortical cells directly by modulating cell growth and 
differentiation, as well as influencing steroidogenesis; these results are supported by the 
discovery of IL-6 receptor expression on steroid-producing cells in adrenal glands (Path et 
al., 1996). 
Suggestions have been made that adrenal IL-6 may act in a paracrine fashion to stimulate 
adrenal secretion of glucocorticoids (Turnbull and Rivier, 1995, Path et al., 1996, 
Franchimont et al., 2000a, John and Buckingham, 2003).  It is known that the adrenal gland 
is the biggest source of IL-6 in response to psychological stress(Zhou et al., 1993), the origin 
of which could likely be attributed to splanchnic nerves penetrating the adrenal capsule.  It 
appears that IL-6, along with catecholamines originating from adrenomedullary chromaffin 
cells, in large amounts stimulate steroidogenesis in a direct manner and probably is one of the 
primary activators of the adrenal cortex by the sympatho-adrenal medullary system 
(Bornstein and Chrousos, 1999).  It is therefore not surprising considering the neuronal origin 
of IL-6 that in vivo studies using intracerebroventricular injections of GABAAR and 
GABABR agonists showed decreased restraint stress-induced plasma IL-6 levels while 
injection of GABAAR and GABABR antagonists resulted in higher basal and stress-induced 
plasma IL-6 levels (Song et al., 1998).  IL-6 therefore constitutes a pivotal component, 
without which the proper function of the sympatho-adrenal medullary system could not be 
achieved. 
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2.4  Potential indigenous anti-anxiety agents 
Sutherlandia frutescens (more commonly known as cancer bush) has been used for its 
medicinal properties for a long time in Southern African countries like South Africa, Lesotho, 
Namibia and Botswana.  It has been used as traditional medicine by a wide variety of cultural 
groups in these areas including the Zulu, Xhosa, Khoi-San and Cape Dutch.  Its uses also 
vary from the treatment of internal cancers, stomach ailments and diabetes to stress and 
anxiety.  The native words for this plant, including the Sotho name motlepelo, meaning 
“bringing back the heart”, or insiswa, an ancient Zulu word meaning “he who dispels 
darkness”, clearly describes a function of this plant in relieving anxiety or depression.  The 
Sutherlandia genus is extremely variable with respect to its chemical, genetic and geographic 
properties and can be subdivided into three subspecies and several regional forms.  Some 
biochemical components of Sutherlandia frutescens, subspecies microphila, or S. frutescens, 
have been identified by chemical analysis. These include substances known to have anti-viral 
and anti-cancer properties, like L-canavinine, and others that have mood-elevating properties, 
such as GABA (van Wyk and Albrecht, 2008).  Another component called pinitol has anti-
inflammatory as well as insulin-like properties (Brummerhoff, 1969, Viljoen, 1969, Moshe, 
1998, Levy et al., 1999).  Previous studies done by our group demonstrated that rats receiving 
chronic daily treatment with S. frutescens warm water extract showed significant attenuation 
of the corticosterone response in when exposed to chronic intermittent restraint stress (Smith 
and Myburgh, 2004).  A complimentary study postulated that the underlying mechanism may 
involve S. frutescens-induced suppression of the cytochrome P450, a catalyst of the 
corticosterone biosynthetic pathway (Prevoo et al., 2004).  However, this cannot account for 
the acute mood-altering effects reported.  The exact mechanisms of this plant’s anti-stress 
action have thus not been fully elucidated and require further investigation.  These 
mechanisms may involve pathways situated in the hippocampus and sympathetic nervous 
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system.  Anecdotally, S. frutescens results in a slight “docile” response, not unlike that 
ascribed to GABA (Mao et al., 1978).  Therefore, it is possible for example, that S. 
fruitescens-derived GABA down-regulates stress perception inhibiting stress-related 
sympathetic signaling.  These theories are supported by reports of anti-convalsant properties 
of S. frutescens that is thought to be mediated by either acting like GABA or by indirectly 
enhancing GABAergic neurotransmission (Ojewole, 2008).  There may thus also be truth in 
the claims that S. frutescens could improve quality of life in cancer and HIV patients, since 
both disease states are associated with chronically elevated glucocorticoid secretion.  S. 
frutescens has been described as an adaptogen, increasing the body’s ability to adapt to and 
resist stress and disease through a process called allostasis (maintenance of homeostasis 
through multiple integrative adaptive processes) (McEwen and Seeman, 1999, Goldstein and 
McEwen, 2002).  S. frutescens therefore constitutes a natural complimentary medicine that is 
worthwhile investigating as a tool against stress, especially in developing countries where 
access to conventional pharmaceuticals is limited. 
2.5  Summary  
Despite popular opinion that glucocorticoid secretion in response to stress is primarily 
mediated by the HPA axis, a growing body of evidence in modern literature suggests that 
adrenocortical function is regulated by a complex interaction between the HPA axis and the 
sympatho-adrenal medullary pathway.  Changes in corticosterone levels do not always mirror 
changes in ACTH levels and support the presence of extra-pituitary mechanisms of adrenal 
regulation (Bornstein and Chrousos, 1999).  Even though the exact ratio of control exercised 
by the respectable pathways is as yet unknown, from an evolutionary point of view, the 
sympatho-adrenal medullary system most likely constitutes the ancestral pathway.  It is 
therefore not unlikely that glucocorticoid secretion, at least in the acute response to stress, 
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could be primarily under the control of the sympatho-adrenal medullary system (fig. 2.4).  
Indicators of psychological stress such as central GABA levels and circulating corticosterone 
levels, as well as major role players in the two pathways (ACTH and IL-6 for the HPA-axis 
and sympatho-adrenal medullary system respectively) were identified and could be used to 
establish an accurate representation of the internal milieu as well as the pathways at work.  S. 
frutescens is also speculated to convey its anxiolytic effects through the alteration of stress 
perception by the induction of inhibitory GABAergic transmission in the hippocampus, the 
major source of inhibitory input to the peripheral limbs of the psychological stress response.   
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2.6  Hypothesis & aims 
After a thorough review of the literature, we hypothesised the following in the context of 
acute psychological stress: 
a.  The sympatho-adrenal medullary system constitutes the primary and the HPA-axis 
the secondary response pathway. 
b. Since S. frutescens contain GABA and has anti-inflammatory properties, it may exert 
its anxiolytic effect via suppression of the sympatho-adrenal medullary system. 
We aimed to test our hypothesis by: 
1.  Inducing an acute mild psychological stress response by means of restraint in male 
Wistar rats 
2. Blocking IL-6 – a major role player in the sympatho-adrenal medullary system - by 
administration of an anti-IL-6 antibody to probe the importance of this pathway 
3.  Investigating the effects of in vivo, acutely administered S. frutescens on 
psychological stress by assessment of alterations to central and peripheral limbs of 
both the HPA-axis and sympatho-adrenal medullary mediated psychological stress 
responses. 
To address these aims, I conducted two separate experiments, both using an established 
rodent model for acute mild psychological stress.  These experiments will be described in the 
next two chapters, in terms of methodology, results and data interpretation. In the final 
chapter, conclusions will be drawn and directions given for further study. 
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Chapter 3 :  The role of IL-6 in the acute response to 
psychological stress 
3.1  Introduction 
With regard to psychological stress, the sympatho-adrenal medullary system has long been 
thought to only be involved in catecholamine secretion from the adrenomedullary chromaffin 
cells.  Evidence of synaptic activity amongst adrenocortical cells has spurred a unified 
approach to adrenal regulation, especially in context of stress-induced activation by 
sympathetic neuronal inputs, since it likely constitutes the evolutionary ancestral pathway.  
We therefore attempt to fully elucidate the importance of the sympatho-adrenal medullary 
system in the acute response to psychological stress by blocking one of its key components, 
IL-6. 
3.2  Methodology 
3.2.1  Experimental animals:  
Forty male Wistar rats (weighing 372 ± 66g) were bred in a local small animal unit and 
housed in standard rat cages.  Rats were fed standard rat chow and tap water ad libitum, while 
the ambient temperature was kept constant at 21ºC.  Rats were subjected to a 12-hour 
light/dark cycle (lights on at 7 am).  Sufficient ventilation was provided at a rate of 10 room 
changes per hour.  For four-five weeks prior to initiation of experimental protocols all rats 
were purposefully handled to accustom them to the investigators, thereby minimizing 
confounding effects of acute experimental experimental stress-variables not related to the 
intervention treatments.   
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3.2.2 Ethical considerations 
All protocols used were approved by the Animal Ethics Committee of Sub-Committee B of 
Stellenbosch University (ref # 20040218CS), and interventions carried out in accordance with 
ethical guidelines of the South African Medical Research Council.   
Detailed intervention protocol for the first experiment performed in this study is described 
below: 
3.2.3  Protocol  
Rats were divided into eight weight-matched groups of five animals per cage, and cages 
randomly assigned to the following 4 experimental groups (i.e. n=10 per group):  Control 
Placebo (CP), Control Antibody (CA), Stress Placebo (SP) and Stress Antibody (SA).    
The timeline for all interventions are presented in Fig 3.1, followed by a more detailed 
description of each intervention. 
 
                                                                                  
 
 
 
 
Figure 3.1.  Schematic representation of experiment 1.  Abbreviations: A, antibody; P, placebo; min, 
minutes. 
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3.2.3.1  Interventions  
IL-6 Antibody preparation: 
To prepare the IL-6 antibody, 100 µg lyophilised goat-derived antibody to rat IL-6 (AF506, 
R&D Systems, Germany) was dissolved in 1 ml of sterile saline according to manufacturer’s 
instructions.  This 100 µg/ml stock solution was subsequently diluted 1:50 in sterile saline to 
yield a final concentration of 2 µg/ml.  One injection per rat were administered i.p. at a 
dosage of 2 µg/kg body weight to groups CA and SA, while sterile saline was administered 
(1ml/kg body weight) to placebo groups (CP and SP).  Rats were allowed 30 minutes to 
ensure thorough absorption of the antibody before commencing with stress exposure. 
Stress model: 
Stress group rats (SP & SA) were subjected to restraint for a period of 60 minutes in purpose-
made individual Perspex cages (dimensions 7 cm x 8 cm x 15 cm), and sacrificed within 
5 min after removal from these cages. Placebo rats were returned to their housing cages for 
the time period between injection and sacrifice. Sacrifice time points for control rats were 
chosen to correspond to that of stressed rats, so that all rats were sacrificed at a time point 90 
minutes after injection of either placebo or the IL-6 antibody.  
3.2.3.2  Sacrifice & Sample collection  
Animals were sacrificed by pentabarbitone sodium overdose (200 mg/kg i.p.).  To exclude 
influences of circadian rhythms on circulating hormone concentrations, all animals were 
sacrificed between 8 and 10 am.   After loss of consciousness, but before cardiac arrest, blood 
was collected from the heart by means of left ventricular puncture using a sterile 20 gauge, 
3.75 cm long needle and a 5 ml sterile syringe, and transferred into lithium heparin tubes 
(Vacutainer, BD Systems, Plymouth, UK).  Tubes were kept on ice and centrifuged at 3000 
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rpm for 10 minutes at 4ºC within an hour of collection.  Plasma was aliquotted and stored at -
80ºC until subsequent batch analysis of cytokine and corticosterone concentrations.   Adrenal 
and pituitary glands were dissected out, cleaned of visible fat and connective tissue and 
weighed on an electronic balance accurate to the nearest milligram (Shimadu, type AW220, 
Phillipines Manufacturing Inc. Japan). Tissue was then fixed in 10% formal-saline for 3 days, 
after which it was processed into paraffin wax blocks using standard histological procedures.  
Between consecutive sacrifices all blood and animal waste were removed and the working 
area disinfected to prevent an acute stress response as a result of the odours of previously 
sacrificed rats.  
3.2.3.3  Sample analysis 
Wax embedded tissue samples were used to prepare 5 µm sections using a rotary microtome 
(Reichert Jung, Heidelberg, Austria). These sections underwent conventional de-
paraffinisation and rehydration processing prior to initiation of staining protocol. Routine 
H&E staining as employed for assessment of histological changes, while more advanced 
immunohistochemical techniques were used (see appendix C for detailed description of 
protocol) to confirm the availability of IL-6 antibody (raised in goat) at tissue level using a 
Texas Red conjugated secondary anti-goat antibody (sc-2783, Santa Cruz Biotechnology Inc., 
Santa Cruz, California, USA).  Haematoxylin and eosin (H&E) stains were also prepared using 
standard histological techniques. 
 
A commercially available enzyme-linked immune-sorbent assay (ELISA)-based bead kit 
system (Bio-Plex, BioRad Laboratories Inc., Parklands, South Africa; refer to Appendix A 
for details) was used for the determination of plasma IL-1β, IL-6, TNF-α concentrations, and 
enzyme-immune-assay (EIA) kits (AC-14F1, Immunodiagnostic Systems Ltd., Frankfurt, 
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Germany) for corticosterone concentrations in duplicate.  Briefly, the Bio-Plex assay employs 
multiplexing technology that uses multiple colour-coded bead sets (three sets for this 
particular experiment), each conjugated with a specific primary antibody (in this case IL-6, 
IL-1β or TNF-α) via a covalent bond.  These antibody-coupled beads are incubated with 
samples and standard solutions to bind to the target molecules, after which unbound proteins 
are washed away. A biotinylated detection antibody specific for a different epitope on the 
cytokine (i.e. another primary antibody) is added to the reaction solution, resulting in 
formation of a sandwich of antibodies around the cytokine.  For detection of fluorescence, 
phycoerythrin labeled streptavidin (streptavidin-PE) is added and binds to the biotinylated 
primary antibodies.  Finally, the content of each well is aspirated by an automated Bio-Plex 
reader, which identifies the parameter (cytokine) according to the colour of the bead bound to 
it, and concentration by fluorescence intensity (a detailed protocol provided in Appendix A). 
The principle of the EIA assay is based on the competitive binding between the endogenous 
molecule of interest and a horseradish peroxidase conjugate.  These two competitively bind to 
antibody-coated microtiter wells during incubation.  After incubation the unbound peroxidase 
conjugate is washed off.  The addition of a substrate solution spurs colour development of the 
conjugate and the intensity of the colour development (assessed by colorimetry using a 96-
well plate reader) is inversely proportional to the concentration of the molecule of interest.  
(Detailed protocol provided in Appendix B). 
3.2.3  Statistical Analysis 
Values for IL-6 were very low across board, with detectable concentrations in less than 50 % of 
samples. Therefore, an arbitrary value of zero was assigned for non-detectable samples, in order to 
facilitate statistical comparison between groups. Data for IL-6 were not normally distributed – 
therefore group differences were assessed using Kruskal-Wallis ANOVA by ranks. Differences 
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between groups for all other parameters were assessed using Factorial ANOVA and Fisher post hoc 
tests (Statistica v.8, StatSoft Software). P<0.05 was set as level of significance. All results are 
reported as means and standard error of means (SEM).  
3.3  Results 
Immunohistochemical analysis of the pituitary and adrenal glands confirmed that i.p. 
injection of the IL-6 antibody did indeed result in the anti-IL-6-antibody becoming 
bioavailable at tissue level, as indicated by staining for the antibody in different target tissues 
(Fig 3.2). This data further suggest that at the point of sacrifice and sample collection, the 
anti-IL-6 antibody had indeed bound to IL-6 (which would have “sequestered” the antibody 
in the particular tissue).  
 
 
 
 
 
 
 
 
Figure 3.2.  Figures are representative samples (n = 4) of posterior pituitary tissue (magnification 
200x) in placebo rats (A) and those injected with anti-IL-6 antibody (B), and adrenal tissue 
(magnification 100x) of placebo (C) and antibody-treated rats (D).  
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Stress had a significant main effect on plasma corticosterone levels (P<0.0001), with stress 
resulting in a more than 5-fold increase in corticosterone levels (P < 0.0001; Fig 3.3), a 
response attenuated when IL-6 was blocked (ANOVA interaction effect of stress and 
antibody treatment, P<0.0001). 
 
Figure 3.3.  Effect of acute restraint stress in the presence or absence of intact IL-6 on plasma 
corticosterone levels, n = 10.  Abbreviations: CP,control placebo, CA, control antibody-treated, SP, 
stress placebo, SA, stress antibody-treated.  
***: P<0.0001, different from all other groups 
Significant effects of stress and/or the blocking of IL-6 were observed for both pituitary and 
adrenal tissue masses. In rats exposed to both stress and IL-6 antibody (SA), pituitary mass 
was significantly greater when compared to all other groups (P < 0.0001; Fig 3.4a), while 
adrenal mass was only increased in stressed rats with intact IL-6 (SP) (P < 0.0001). Of 
interest is the fact that in this group, the increase in adrenal mass was accounted for by 
increased gland size on the left side only (Fig 3.4b).  Average right adrenal glands showed no 
significant differences between groups and were measured as 34.7 ± 1.5mg for CP, 35.5 ± 
1.3mg for CA, 37.2 ± 1.7mg for SP and 36.6 ± 1.8mg for SA.  
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(a) 
 
 (b) 
 
Figure 3.4.  Average mass of pituitary gland (a), and left adrenal gland (b). n = 10.  Abbreviations: 
CP,control placebo, CA, control antibody-treated, SP, stress placebo, SA, stress antibody-treated 
***: P<0.0001, different from all other groups. 
Neither stress, nor anti-IL-6-antibody administration significantly affected circulating IL-6 
concentrations (Fig 3.5a).  Plasma IL-1β concentration exhibited an ANOVA main effect of 
antibody treatment (P<0.01) that was independent of stress, with post hoc analysis indicating 
significantly higher values for CP when compared to both antibody-treated groups (CA and 
SA;  Fig 3.5b).  TNF-α levels exhibited an ANOVA main effect of antibody treatment 
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(P<0.01), as well as a significant interaction effect of stress and antibody treatment (P<0.05; 
Fig 3.5c). Post hoc analysis indicated lower TNF-α values in antibody-treated rats, an effect 
attenuated in response to stress. (Lower detection limits of the cytokine assay kits used were 
0.2, 1.7 and 0.2 pg/ml for IL-1β, IL-6 and TNF-α respectively.) 
 
 (a) 
 
 (b) 
 
Figure 3.5.  Effect of acute restraint stress in the presence or absence of intact IL-6 on inflammatory 
cytokines: (a) IL-6 and (b) IL-1β, n = 10.  Abbreviations: CP,control placebo, CA, control antibody-
treated, SP, stress placebo, SA, stress antibody-treated.  Broken line represents lower detection limit 
(1.7 ng/ml) of assay. 
**: P<0.001, different from all other groups 
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(c)  
 
Figure 3.5 (continued).  Effect of acute restraint stress in the presence or absence of intact IL-6 on 
inflammatory cytokine: (c) TNF-α, n = 10.  Abbreviations: CP,control placebo, CA, control antibody-
treated, SP, stress placebo, SA, stress antibody-treated. 
***: P<0.001, different from CP and SP;   *: P<0.05, different from SA. 
3.4  Discussion 
The main findings reported here, as assessed at a single time point after 60 minutes of acute 
restraint in rats are a) that restraint stress led to a significant increase in plasma corticosterone 
levels compared to control groups only in the presence of IL-6, b) an increase in left adrenal 
mass in response to stress which was attenuated in the absence of IL-6, c), an increase in 
pituitary weight during stress only when IL-6 was blocked and d) decreased IL-1β and TNF-α 
concentrations when blocking  IL-6 in the absence of stress. 
Although average IL-6 concentrations in antibody-treated groups were somewhat lower when 
compared to their respective controls, these differences did not reach statistical significance. 
All IL-6 levels were very low, which in combination with high variability between animals, 
may have obscured both an effect of stress and the effect of blocking IL-6 using the antibody. 
Another likely possibility is that the transient increase in IL-6 release, known to occur via 
adrenaline stimulation in response to stress (DeRijk et al., 1994), was never detectable in 
circulation. In a study performed by Uchiyama et al. (2008), it was found that in models of 
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collagen-induced arthritis elevations in blood IL-6 was only detectable after blocking of IL-6 
receptor (IL-6R).  They concluded that the elevations were only seen due to the blocking of 
the IL-6-clearance effect brought on by IL-6R (Uchiyama et al., 2008).  It is therefore 
reasonable to argue that plasma IL-6 levels do not accurately reflect the events at tissue level, 
considering it has its primary function at tissue level where it is secreted, resulting in only a 
fraction of secreted IL-6 reaching the circulation. Despite this, since we were able to illustrate the 
presence of IL-6 antibody at tissue level, and measured circulating IL-6 levels below the assay 
detection threshold in 70% of antibody-treated animals, we are confident that we did in fact block IL-
6 to an extent sufficient to evaluate its role in the stress response.  
In previous studies by our group, repeated restraint stress induced up to ten-fold increases in 
serum corticosterone levels (Smith and Myburgh, 2004, Smith et al., 2007) Our findings of 
increased corticosterone is in agreement with this, as well as similar reports by other research 
groups (Pitman et al., 1988, Dronjak et al., 2004), in both acute and chronic models.  The 
attenuated corticosterone response to stress when IL-6 was blocked (SA) supports an earlier 
report of direct stimulation of adrenal cortical cells by IL-6 to secrete corticosterone in an in 
vitro model (Franchimont et al., 2000a).  Although neuronal-derived IL-6 has been shown to 
play an integral part in corticosterone secretion in in vivo models of repeated psychological 
stress (Smith et al., 2007), this is the first study showing this role of IL-6 in an in vivo model 
of acute  psychological stress. 
The finding that adrenal mass increased in response to stress only when IL-6 was intact, 
further points to a direct stimulatory effect of IL-6 at adrenal level. These results are in 
agreement with the literature (Turnbull and Rivier, 1995, Path et al., 1996, Franchimont et 
al., 2000a, John and Buckingham, 2003). Of special interest, is the finding that mainly left 
adrenal mass increased in stressed animals with intact IL-6.  From the literature, we know 
that asymmetry exists in the intensity of splanchnic innervation of the adrenals, with the left 
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adrenal receiving more cerebral neural inputs than the right adrenal (Toth et al., 2008a, Toth 
et al., 2008b).  The functional significance of the asymmetry in the control of adrenal 
function is not yet known.  An influencing factor of the left adrenal hypertrophy could be the 
light/dark cycle used.  The contribution of this factor will be discussed in section 4.4.  Our 
model seems to suggest that the central sympathetic signal travelling through the splanchnic 
nerves to the adrenal medulla stimulates the adrenomedullary chromaffin cells to release IL-
6, which act in a auto-/paracrine fashion to stimulate glucocorticoid secretion from the 
adrenocortical cells.  The primary signal transduction in response to psychological stress is 
therefore transmitted via the sympatho-adrenomedullary pathway rather than systemically via 
the circulating stress-associated hormones, a.k.a. the HPA axis.  
H&E analysis of adrenal glands supports this result by showing marked increases in the 
number of activated adrenocortical cells of the zona fasciculata in left adrenals (Fig. 3.6A) 
compared to right adrenals (Fig. 3.6B) in SP rats.  It is therefore certain that hyperplasia, and 
possibly hypertrophy, can account for increases in adrenal mass.  Decreased stores of 
intercellular cholesterol droplets or liposomes were also observed in left adrenal glands, 
indicating higher substrate utilization and therefore increased cellular activity.  Literature 
indicates that the above mentioned characteristics are indicative of higher glucocorticoid 
production in adrenocortical cells (von Euler, 1967). 
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Figure 3.6.  Effect of acute restraint stress on left (A) vs. right (B) adrenocortical cell activation with 
white arrows indicating activated cell nuclei and black arrows indicating liposomes, n = 4. 
Pituitary gland mass was not influenced by either blocking IL-6 in absence of stress, or by 
stress alone. However, in contrast to the results obtained in the adrenals, only when blocking 
IL-6, did restraint stress result in a marked increase in pituitary mass.  This suggests a 
stimulatory effect of the gland in the absence of IL-6. There is more than one possible 
explanation for this result. Firstly, IL-6 may produce direct negative feedback to the pituitary 
to limit HPA-associated corticosterone release.  This is however unlikely, since IL-6 is 
known to stimulate the pituitary gland to secrete ACTH by increasing phosphorylation of 
signal transducer and activator of transcription (STAT)-3 in pituitary corticotrophs (Jankord 
et al., 2007). Secondly, it is possible that the lower corticosterone concentration seen in SA 
compared to SP may have provided too little negative feedback to the pituitary, resulting in 
continued activity of the gland, thus suggesting a more indirect central action for IL-6. 
However, the fact that pituitary mass did not change at all in SP, where corticosterone release 
increased almost 6-fold, argues against a major role for the pituitary in this response. A third, 
more likely, alternative is that while sympathetically-induced corticosterone release was 
possible when IL-6 was intact (SP), in SA this pathway was largely incapacitated, and 
required the endocrine support facilitated via the traditional HPA-axis to accomplish a 
A B 
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glucocorticoid response, resulting in the increased stimulation of the pituitary and therefore 
increased pituitary mass. 
Stress alone had no significant effect on TNF-α release, a result supported by the literature, 
since TNF-α release has previously been shown to be unresponsive to both chronic and more 
acute psychological stressors (Goebel et al., 2000, Smith and Myburgh, 2004).  The decrease 
plasma IL-1β concentrations seen in SP compared to CP was probably due to an anti-
inflammatory effect of stress-induced increase in corticosterone.   
The blocking of IL-6 resulted in decreased IL-1β and TNF-α levels in control animals. This is 
not in agreement with the effect reported for IL-6 in the stress literature, where IL-6 is known 
to inhibit IL-1β production in models of sepsis (Aderka et al., 1989, Arbo et al., 1990, 
Schindler et al., 1990, Barton and Jackson, 1993). However, the current result obtained from 
control animals is in agreement with previous work by our group in a chronic restraint stress 
model, which also suggested a role for IL-6 in maintaining basal IL-1β levels (Smith et al., 
2007). It is also further supported by an earlier report that in vitro IL-6 administration 
increased IL-1β mRNA levels in leukocytes in the absence of an added stressor (Panzer et al., 
1993).   IL-1β has also been implicated, along with IL-6, to constitute an integral part of 
sympathetic neurotransmission (Xia et al., 1999).  Therefore, the decreased ability to 
maintain plasma IL-1β levels in the absence of IL-6 supports our notion for decreased 
sympathetic nervous excitation.  With regard to TNF-α, IL-6 seemed to also have a role to 
ensure its continued release, an effect again only evident in unstressed conditions. This is 
again in contrast with the literature, which suggests a role for IL-6 in down-regulation of 
TNF-α (Aderka et al., 1989, Schindler et al., 1990, Nukina et al., 1998a). However, the 
inhibitory effect of IL-6 on LPS-induced TNF-α secretion was previously shown to be limited 
to macrophage lineages, while microglial cells were not affected (Di Santo et al., 1997), 
suggesting that the down-regulatory effect does not occur in a homologous fashion in all cell 
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types. Furthermore, the above-mentioned reports of IL-6-associated inhibition of TNF-α 
release were generated from assessments in non-physiological models of stress or pathology 
such as sepsis, and, as in the case of IL-1β, not under unstressed conditions. From this 
literature, it is not possible to conclude what the effect of IL-6 on TNF-α release would be 
under basal conditions. It is therefore possible that under basal conditions IL-6 could exert an 
opposite effect on TNF-α release, similar to its reciprocal effect on IL-1β, as reported here.  
 Taken together, these results suggest that in the immediate response to acute stress, the 
stimulatory effect on the adrenal cortex to initiate glucocorticoid release is under direct neural 
control, facilitated through the sympatho-adrenal medullary system.  Whether or not this 
extrapituitary-adrenocortical stress response is evolutionary exclusive or additive is important 
in order to understand the biological relevance of such a pathway.  The answer to this 
question seems to be species-dependent, with only mammalian organisms requiring ACTH 
for normal adrenocortical function.  In non-mammalian species, on the other hand, the 
steroidogenic function of ACTH can be fulfilled by local paracrine mechanisms involving IL-
6.  (These mechanisms were discussed in section 2.3.6.)  Even though rodents in fetal or early 
postnatal stages of life may maintain adrenocortical steroidogenesis without pituitary ACTH 
secretion, in adult mammals the loss of pituitary ACTH leads to adrenal atrophy (Bornstein 
and Chrousos, 1999).  Since the HPA-axis is not needed in non-mammalian species, and only 
becomes essential for survival during later stages of life in mammals, it likely constitutes an 
evolutionary derived pathway with the sympatho-adrenal medullary system forming the 
evolutionary ancestral stress pathway.  Our results support this theory since pituitary 
hypertrophy only occurred during the blocking of the sympatho-adrenal medullary system 
with no changes in plasma corticosterone seen while this system was suppressed (Fig. 3.7). 
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Figure 3.7.  Schematic representation of the pathways involved in stress signal transduction after 
blocking IL-6 with blue indicating the activated pathway. 
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Chapter 4  
Central and peripheral effects of S. frutescens in the context of the 
acute response to psychological stress 
4.1.  Introduction          
Depression, along with other anxiety-related ailments, is increasingly prevalent globally, 
especially in developing countries such as South Africa (Yusuf et al., 2001).  Depression is 
also known to be highly prevalent precursor to suicide (Heila et al., 1997), which was 
recently reported to be a major cause of death in South Africa  (Stafford et al., 2008).  Access 
to health care is limited, with only 15% of the population covered by private medical aid 
systems (Eastman, 2005).  Traditional healers outnumber conventional western health 
professionals by at least ten to one (Morris, 2001).  S. frutescens therefore constitutes a viable 
and easily obtainable alternative to conventional pharmaceuticals and merits further 
investigation.  Before large scale distribution, the mechanisms involved in the reported 
anxiolytic effects must be elucidated to exclude possible side-effects not evident from 
anecdotal evidence or the limited number of scientific studies.  Even though the application 
of S. frutescens will likely be chronic we will be using an acute model in order to facilitate 
assessment of the central effects of S. frutescens.  
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4.2  Methodology 
4.2.1  Experimental animals 
Wistar rats were bred, fed and housed under similar conditions as the previous experiment 
with the exception of a reversed light dark cycle (lights off at 7am). 
4.2.2  Ethical considerations 
All protocols used were approved by the Animal Ethics Committee of Sub-Committee B of 
Stellenbosch University Council (ref # 2009B02001), and interventions carried out in 
accordance with ethical guidelines of the South African Medical Research.   
Detailed intervention protocol for the second experiment performed is described below: 
4.2.3  Protocol 
Forty rats were divided into weight-matched groups of five animals per cage, and four 
experimental groups (n=10 per group) randomly assigned as follows:  Control Placebo (CP), 
Control S. frutescens (CSu), Stress Placebo (SP) and Stress S. frutescens (SSu).  As in chapter 
3, the timeline of the intervention protocol is illustrated below (Fig. 4.1), followed by a more 
detailed description of procedures. 
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Figure 4.1.  Schematic representation of interventions in experiment 2. Abbreviations: Su, S. 
frutescens; Pla, placebo; min, minutes. 
 
4.2.3.1  Interventions 
S. frutescens-treatment: 
The S. frutescens used was harvested in the vicinity of Murraysburg, Western Cape Province, 
South Africa, and identified as S. frutescens subspecies mycrophilla by Prof B-E van Wyk 
from the University of Johannesburg Botany department (Voucher specimen B-E. van Wyk 
4126 (UJ)).  According to the recommended dosage of commercially available S. frutescens, 
9 mg per kg body mass per day is the optimal dose in humans. This dose was translated and 
rounded up to a daily effective dose in rats of 4 mg per kg. Traditionally, S. frutescens is 
administered as an herbal infusion – in keeping with this, we prepared a warm water extract 
by adding dried S. frutescens leaves to boiling water (4mg/ml), allowing infusion with 
agitation for an hour.  To minimise confounding effects of variations in plant material, the S. 
frutescens extract was prepared in one batch and aliquots frozen, for single use at each 
(staggered protocol) treatment time point. Although each rat was supplemented only once, 
Lights off 
0  min 30 min 90 min 
Control 
Stress 
Restraint 
Gavage (Su/Pla) Sacrifice 
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entrance into protocol was staggered to allow for synchronized diurnal rhythm resulting in 
more than one treatment time point.  Since the extract is traditionally administered orally, rats 
were orally gavaged with 1 ml/kg body mass only once, as indicated in Fig. 4.1.  The S. 
frutescens extract was prepared in tap water to simulate the historical use thereof and 
therefore placebo rats were given tap water at a dose of 1ml/kg body weight. 
Stress model: 
Stress group rats were restrained for a period of 60 min in a purpose-made Perspex cage 
(dimensions 7 cm x 8 cm x 15 cm) starting 30 min after S. frutescens treatment, and 
sacrificed within 5 min of removal from these cages. Placebo rats were kept under normal 
housing conditions and in standard cages for this same time period. All rats were thus 
sacrificed at a time point 90 minutes after gavage with S. frutescens extract.   
4.2.3.2  Sacrifice & Sample collection 
Since this study had a neurophysiology component, we attempted to avoid euthanasia-
induced alterations in the central components of stress circuitry by using decapitation as 
method of sacrifice. Once again, all animals were sacrificed between 8 and 10 am to exclude 
influences of circadian rhythms on circulating hormone concentrations.  Blood was collected 
from jugular bleeding resulting from decapitation, into heparinised tubes (Vacutainer, BD 
systems, Plymouth, U.K.).  Blood tubes were kept on ice and centrifuged at 3000 rpm for 10 
minutes at 4 ºC within an hour of collection.  Plasma was aliquotted and stored at -80 ºC until 
subsequent batch analysis of testosterone, ACTH and corticosterone concentrations.   Rat 
brains were dissected out and mid-sections frozen in OCT in liquid nitrogen-cooled 
isopentane.  Whole adrenal and pituitary glands were also dissected out, cleaned and weighed 
on an electronic balance accurate to the nearest milligram. They were then fixed in 10% 
formal-saline for three days, after which it was processed into paraffin wax blocks using 
standard histological procedures.  Between consecutive sacrifices all blood and animal waste 
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were removed and the working area disinfected to prevent an acute stress response due to the 
odours of previously sacrificed rats.  
4.2.3.3  Sample analysis 
Plasma samples were analyzed using EIA kits according to the manufacturers’ instructions 
for ACTH (Biomerica, Newport Beach, California, USA) corticosterone (Immunodiagnostic-
systems, Boldon Business Park, UK), and testosterone (DRG Diagnostics GmbH, Germany) 
(Appendix B).  
Brain tissue samples were prepared into 10µm cryosections using a cryostat (CM 1100, Leica 
Nussloch, Germany) and subjected to immunohistochemical analysis (Appendix C) of 
GABAARα1 and GR levels. GABAAR was detected using an anti-human GABAAR goat IgG 
(Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) raised against the GABAARα1 
subunit of the receptor followed by a Texas Red conjugated secondary antibody  (Santa Cruz 
Biotechnology Inc., Santa Cruz, California, USA). The GR was detected using a rabbit 
polyclonal IgG raised against human GR (Santa Cruz Biotechnology Inc., Santa Cruz, 
California, USA) and visualized by using a fluorescent conjugated secondary antibody (Santa 
Cruz Biotechnology Inc., Santa Cruz, California, USA).  
Pituitary and adrenal tissue samples were cut into 5µm sections using a rotary microtome 
(Leica RM 2125, Germany) and prepared for immunohistochemical analysis of ACTH 
expression as well as IL-6 levels in the adrenal tissue (Appendix D).  Immunoperoxidase 
staining of tissue sections was carried out using the avidin-biotin complex (ABC) staining 
system (Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) according to the 
manufacturers’ instructions. Pituitary and adrenal samples were incubated with a monoclonal 
primary anti-mouse ACTH IgG (Novus Biologicals, Littleton, Colorado, USA). For the 
detection of IL-6 in adrenal tissue only, a polyclonal anti-mouse IL-6 IgG (Santa Cruz 
Biotechnology Inc., Santa Cruz, California, USA) was used.  
57 
 
4.2.3.4  Image analysis 
Two sections per slide were prepared and a negative control stain (PBS control) was 
performed with both secondary antibodies in order to verify true positive staining.  Photos 
were taken of three fields of view in the hippocampus (CA1 regions) of every section, two 
sections per slide. One slide per sample was made for four samples in every group.  Photos 
were taken at 40x magnification using a microscope (Nikon ECLIPSE E400; 400x objective 
used), equipped with a colour digital camera (Nikon DXM1200) and computer software for 
acquiring digital images (Simple PCI version 4.0, Compix Inc., Imaging Systems, USA).  All 
photos were taken using identical filters, exposure times and sensitivity settings.  All photos 
were analyzed using the software package Image J version 1.41O (Rasband, 1997-2009). The 
Mean Gray Value (the sum of the gray values of all the pixels in the selection divided by the 
number of pixels) for the images was automatically calculated and each pixel automatically 
converted to grayscale, using the following formula: gray = (red + green + blue) / 3. The 
fluorescence unit obtained refers to the relative area of the image that fluoresces, not to 
fluorescent intensity.  This measurement is fully automated and the software was obtained 
from the National Institute of Health (NIH), allowing one to assume that it is of sufficient 
quality.  However, as is the case with all fluorescent analysis, this technique has a subjective 
component in that the researcher has to adjust image brightness to exclude excessive 
background staining or increase sensitivity. Nevertheless, this is common practice, and in the 
current study, all analysis was performed by one researcher (the candidate) only, thereby 
avoiding variation in the data due to researcher-specific differences in means of analysis.  
Once a specific profile of settings has been optimized, these settings were used for all images 
for a particular magnification and parameter. 
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4.2.4  Statistical analysis 
Values obtained for ACTH were very low, with many values lower than the allowed 
detection limit of kits used, and therefore an arbitrary value of zero was assigned to these 
values, in order to facilitate statistical comparison between groups.  N = 10 were used for the 
analysis of plasma concentrations of ACTH, corticosterone and testosterone while an n = 4 
were used during immunohistochemical analysis of the hippocampal GABAARα1 and GR as 
well as adrenal ACTH and IL-6 levels.  Correlation analysis between circulating 
corticosterone and hippocampal GR were performed.  Differences between groups for all 
parameters were assessed by Factorial ANOVA and Fischer post hoc tests (Statistica v.9, 
StatSoft Software). P<0.05 was set as level of significance. All results are reported as means 
and standard errors of means (s.e.m.). 
4.3  Results 
One-way ANOVA analysis indicated a significant main effect of stress on serum 
corticosterone levels with increased levels found in both groups exposed to restraint, when 
compared to their respective controls (P < 0.0001, Fig 4.2).  S. frutescens did not have a 
statistically significant effect on corticosterone levels.  Lower detection limit for this assay 
was 1.7 ng/ml. 
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Figure 4.2.  Effect of acute restraint stress and/or of S. frutescens on plasma corticosterone 
concentrations, n = 10.  Abbreviations:  CP, control placebo, SP, stress placebo, CSu, control S. 
frutescens-treated, and SSu, stress S. frutescens-treated. 
***:  P < 0.0001, different from control groups 
Immunohistochemistry data illustrated a tendency of hippocampal GABAARα1 to decrease in 
the presence of both stress and S. frutescens administration (P = 0.068; Fig. 4.3a.).  
Hippocampal GABAARα1 levels in CA1 regions decreased by 21.5% after S. frutescens 
administration, 28.8% after exposure to restraint and 47.8% after both S. frutescens 
administration and restraint.  Although these changes were not statistically significant, they 
may have clinical importance.  Representative photos taken of the CA1 regions of the 
hippocampus are shown in Fig 4.3b. 
Hippocampal GR showed no significant effects of either stress or S. frutescens 
administration, likely due to high variability seen in control groups (Fig 4.4a).  However, 
restraint caused an average 39.8% decrease in hippocampal GR in placebo-treated groups and 
a 47.9% decrease after S. frutescens-treatment.  Representative photos of the CA1 regions of 
the hippocampus and are shown in Fig 4.4b. 
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(a) 
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Figure 4.3.  Effect of acute restraint stress and/or S. frutescens on hippocampal GABAARα1, n = 4.   
Abbreviations:  CP, control placebo, SP, stress placebo, CSu, control S. frutescens -treated, and SSu, 
stress S. frutescens –treated shown in (a), and representative samples of CP and stress SSu rat 
hippocampal sections (magnification 400x) visualized for GABAARα1 shown in (b).  
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(a) 
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Figure 4.4.  Effect of acute restraint stress and/or S. frutescens on hippocampal GR, n = 4.  
Abbreviations: CP, control placebo, SP, stress placebo, CSu, control S. frutescens-treated, and SSu, 
stress S. frutescens-treated shown in (a), and representative samples of CP, CSu, SP, and SSu rat 
hippocampal sections (magnification 400x) visualized for GR shown in (b). 
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ACTH levels in the anterior pituitary show a gradual increase brought on by S. frutescens-
treatment and restraint stress independently as well as cumulatively (Fig 4.6).  S. frutescens-
treatment led to a 51.1% increase, stress led to a 206.1% increase and a combination of the 
two led to a 357.6% increase in ACTH levels, with SP > CSu (P < 0.05). 
No statistically significant effect of stress on circulating ACTH concentrations were seen in 
placebo groups (Fig 4.7),  despite a major increase in SP vs. CP – this was probably due to 
increased variation in SP.  Statistically significant differences in ACTH levels were also 
found between stress and control groups treated with S. frutescens where stressed rats showed 
higher concentrations than control rats treated with either placebo or S. frutescens (P < 0.05).  
These stress-induced effects, which occur only in the presence of S. frutescens, point to a 
possible interaction effect between stress and S. frutescens.  A noteworthy tendency towards 
increased ACTH levels in SSu vs. SP (P = 0.074) was also observed.  A relatively high inter-
individual variation was observed in both SP and SSu for this parameter.  Lower detection 
limit for this assay was 1.5 pg/ml. 
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Figure 4.5.  Effect of acute restraint stress and/or of S. frutescens on anterior pituitary ACTH 
concentrations, n = 4.  Abbreviations:  CP, control placebo, SP, stress placebo, CSu, control S. 
frutescens-treated, and SSu, stress S. frutescens-treated. 
 
 
 
 
Figure 4.6.  Effect of acute restraint stress and/or S. frutescens administration on plasma ACTH 
concentrations, n = 10.  Abbreviations:  CP, control placebo, SP, stress placebo, CSu, control S. 
frutescens-treated, and SSu, stress S. frutescens-treated. 
*:  P < 0.05, different from CSu and CP. 
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No statistically significant effects of either stress or S. frutescens alone were seen in pituitary 
mass.  However, with exposure to both stress and S. frutescens, rat pituitary mass tended to 
be higher.   (SSu > CP; P = 0.08; Fig 4.8a).  Adrenal mass showed a significant decrease in 
CSu that was attenuated in response to stress (P < 0.05; Fig 4.8b).   
Adrenal levels of ACTH showed a reciprocal trend to pituitary and circulating ACTH levels 
with SSu showing sharp decreases (P < 0.05) and SP showing a tendency (P = 0.075) 
compared to CP animals (Fig 4.9a).  No statistically significant differences were seen in 
adrenal IL-6, increases were seen with administration of S. frutescens (38.8%), stress 
exposure (43.3%) and a 58.2% increase seen with both S. frutescens-treatment and stress 
exposure (Fig 4.9b). 
 
Neither stress, nor S. frutescens administration had any effect on serum testosterone levels.  
Average testosterone concentrations were 9.27 ± 0.42 ng/mL for CP, 10.38 ± 2.02 ng/mL for 
SP, 10.56 ± 2.21 ng/mL for CSu and 9.52 ± 1.56 ng/mL for SSu.  Lower detection level for 
this assy was 83 pg/ml. 
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(a) 
 
 (b) 
                          
Figure 4.7.  Effect of acute restraint stress and/or S. frutescens on (a) pituitary mass and (b) average 
adrenal mass, n = 10. Abbreviations:  CP, control placebo, SP, stress placebo, CSu, control S. 
frutescens-treated, and SSu, stress S.frutescens-treated. 
*:  P < 0.05, different from CP and SSu. 
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(a) 
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Figure 4.8.  Effect of acute restraint stress and/or S. frutescens on (a) adrenal ACTH and (b) adrenal 
IL-6, n = 4.  Abbreviations:  CP, control placebo, SP, stress placebo, CSu, control S. frutescens-
treated, and SSu, stress S.frutescens-treated. 
*: P < 0.05, different from CP 
 
4.4  Discussion 
The current study yielded the following main findings:  A major increase in plasma 
corticosterone levels was seen after exposure to restraint stress that was not significantly 
affected by acute S. frutescens-administration.  A tendency of GR levels to decrease in 
response to restraint as well as a subtle decrease in GABAAR levels was also seen in the CA1 
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region of the hippocampus. This is thought to be achieved synergistically by exposure to 
restraint stress and S. frutescens treatment.  Thus, contrary to our hypothesis, S. frutescens did 
not lead to an attenuated psychological stress response by increased GABAergic function.  A 
subtle tendency of pituitary mass to increase with the combination of stress and S. frutescens-
treatment was observed which coincided with an increase in anterior pituitary ACTH levels 
in SSu animals. Plasma ACTH levels increased in response to stress and this increase also 
seemed to be exacerbated in the presence of S. frutescens. Decreased adrenal mass was seen 
in response to treatment with S. frutescens, this decrease was attenuated by stress exposure.  
A significant decrease in adrenal ACTH levels in response to both stress and S. frutescens-
treatment was seen.  The consistent patterns observed throughout the results, albeit subtle for 
some parameters, affirm a tendency for causality between the separate changes.   
As reported in Chapter 3, acute restraint once again resulted in a significant increase in 
plasma corticosterone levels.  However, contrary to previous studies performed by our group 
using a chronic supplimentation model of intermittent restraint stress (Prevoo et al., 2004), S. 
frutescens had no effect on corticosterone production during acute stress.  Since the acute 
model was chosen in order to elucidate the central effects of S. frutescens-administration it 
may not be ideal for analyzing the peripheral effects.  Corticosterone release occurs within 
minutes of stress perception (Hess et al., 1968) and could precede the effects of S. frutescens 
since enough time may not have passed for the S. frutescens to become bioavailable.  
Corticosterone also has a half-life of 20 to 25 minutes in male rats (Kitay, 1961, Sainio et al., 
1988) and would still be detectable at the time point of sacrifice which is likely why no effect 
of S. frutescens on circulating corticosterone concentrations was seen in the acute model. 
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The lack of statistically significant differences between groups with regard to GR could be 
attributed to large variability seen in control groups, indicating variable baseline 
concentrations in control groups.  This variability is likely due to the social hierarchy that 
exists between rats housed together in a cage, resulting in lower basal GR levels in socially 
submissive animals relative to dominant animals.  Chronic social stress has been shown to 
induce steroid induce nerve growth factor (NGF) release, which functions as a GR inhibitor, 
and eventually cause steroid insensitivity (Sheridan et al., 2000).  This result, however, is 
unavoidable in a stress model, since housing rats separately would lead to isolation stress 
(Hatch et al., 1963) which would also influence the results.  The variability seen in control 
groups seem to decrease in SP rats indicating a more uniform response of GR to decrease 
with psychological stress-induced corticosterone increases.   
Another possibility that could explain the trend seen for GR to decrease in response to stress, 
is the conformational changes which occur once the GR binds a ligand.  The GR antibody 
was raised against 300 residues lying in an internal region of the protein which may undergo 
conformational changes and therefore mask the epitope resulting in lower signals being 
obtained for the complexes.  In addition, compounds found within S. frutescens which are 
structurally similar to corticosterone may also complex with the GR, resulting in a lowered 
signal.  This could also result in downstream effects similar to the natural ligand, possibly 
explaining the raised corticosterone levels seen in CSu. 
The tendency of hippocampal GR to decrease in response to stress is supported by previous 
studies by our group and others which showed similar result in a chronic model of restraint in 
liver tissue (Omrani et al., 1980, Sapolsky et al., 1984, Smith et al., 2007).  It has been shown 
that chronic stress causes atrophy in the CA3 region of the hippocampus (McKittrick et al., 
2000), while both chronic as well as acute stress leads to suppression of neurogenesis in rats.  
This psychological stress-induced damage results in cognitive impairment in the learning of 
69 
 
spatial and short-term memory tasks (McEwen and Sapolsky, 1995).  These detrimental 
effects are known to be caused by stress-induced corticosterone secretion and binding to GR 
(Pavlides et al., 1994, McEwen and Sapolsky, 1995, Pavlides et al., 1995, Cameron and 
Gould, 1996, Conrad et al., 1996, Pavlides et al., 1996, Gould et al., 1997, de Kloet et al., 
1998b).  Our result is novel in that it is the first time that this well characterized adaptation of 
GR to chronic psychological stress (Magarinos et al., 1996) has been illustrated after acute 
exposure to stress.   
It has been shown that orally ingested GABA remains intact through the absorption process 
and is capable of crossing the blood brain barrier (Kuriyama and Sze, 1971).  The anecdotal 
mood altering effects of S. frutescens along with its GABA content (Tai et al., 2004) would 
suggest an ability to increase GABA content, resulting in increased inhibitory 
neurotransmission function of GABAergic neurons.  Since acute stress has been shown to 
down-regulate GABA receptor function (Barbaccia et al., 1996), it would be expected that S. 
frutescens administration would attenuate the stress-induced GABA down-regulation.  
Attenuation of stress-induced GABA down-regulation is expected to result in a continued 
GABAAR activity and GABAergic function within the CA1 region of the hippocampus.  
However, the tendency for hippocampal GABAAR to decrease in the presence of both 
psychological stress and S. frutescens suggests that the combination of acute stress exposure 
and S. frutescens is adequate to induce this slight down-regulation of GABAAR.  These 
conclusions are however based on tendencies and a larger sample size will be required to 
confirm our suspicions.  
A possible explanation for the tendency of GABAAR levels in the hippocampus to decrease 
could be the bipolar nature of the GABA neurotransmitter.  Recent evidence demonstrated 
that GABA may transiently act as an excitatory transmitter after intense bursts of GABAAR 
activation in the brain.  This is due to an activity-dependent shift in chloride reversal potential 
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which causes a reversed polarity of GABAergic postsynaptic responses (Isomura et al., 
2003).  This phenomenon has been observed in the mature CA1 region of the hippocampus 
(Fujiwara-Tsukamoto et al., 2003) and likely occurs because of the fine and complex 
structure of neurons.  Asymmetric intracellular Cl- activities caused by variations in Cl- fluxes 
through ion channels or by asymmetric expression and activities of Cl- transporters are 
thought to cause the change in function of GABAergic synapses from hyperpolarization to 
depolarization (Walters, 2004).  The prolonged activation of GABA brought on by the 
addition of external plant-derived GABA, could therefore bring about this functional shift, 
depolarizing presynaptic glutamatergic nerve terminals projecting to hypothalamic neurons, 
leading to subsequent excitatory glutamate release (Jang et al., 2001).  The addition of S. 
frutescens-derived GABA in our model may thus have resulted in a burst in GABA activity 
in the hippocampus shortly after administration, leading to a phenomenon known as 
“afterdischarge” (persistence of response of neural elements after cessation of stimulation) 
(Millhorn et al., 1980), where a functional shift in GABAergic neurons causes the 
depolarization of glutamatergic neurons and excitatory neurotransmission.  The saturation of 
GABAergic receptors could therefore lead to a down-regulation of GABAAR.  This is 
supported by the tendency for decreased GABAAR seen in the hippocampal CA1 region. 
Inhibition of GABAAR mediated synaptic transmission has also been observed in 
hippocampal CA1 neurons after acute cannabinoid administration (Katona et al., 1999).  
Cannabinoids such as tetrahydrocannabinol (THC) are the primary mood-elevating elements 
found within marijuana, a shrub which is also known for its anxiolytic effects.  The inhibitory 
effects of cannabinoids on GABAergic neurons are shown to be mediated through 
cannabinoid-receptor 1 (CB1) and likely involves down-regulation of presynaptic voltage-
dependent Ca2+ channels (Hoffman and Lupica, 2000, Katona et al., 2001, Wilson et al., 
2001, Wilson and Nicoll, 2001).  Even though the exact mechanisms of this CB1 mediated 
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inhibition of hippocampal GABAergic neurons are still unknown, it could be postulated that 
similar mechanisms could be at work after S. frutescens administration since it shows a 
tendency for GABAAR to decrease in hippocampal CA1 regions- an effect shown to be 
present after acute marijuana administration as well.  It is possible that S. frutescens activates 
an endogenous cannabinoid (endocannibinoid) pathway that mimics the effects of marijuana 
use.  It is also possible that S. frutescens mediates its anxiolytic effects in a similar fashion as 
marijuana, which is postulated to decrease inhibitory GABAergic neurotransmission in the 
hippocampus and amygdala, causing an increased glutamatergic outflow which in turn 
activates the mesolimbic dopamine pathway (the primary reward pathway) (Nestler and 
Carlezon, 2006).  These effects may be perceived differently between species, and while 
humans perceive the effect as anxiolytic, rats may perceive the experience as intoxication and 
therefore might experience a psychological stress response.  Further studies examining the 
effects of S. frutescens administration prior to an acute stress response in humans, using a 
model of public speaking for example, is needed to shed more light on this matter. 
This theory is supported by the tendency for mass-increases seen in pituitary glands of rats 
exposed to both stress and S. frutescens treatment (P = 0.078).  Neither S. frutescens, nor 
stress alone had a significant effect on pituitary mass.  Exposure to acute restraint stress 
combined with the S. frutescens-induced increase in neuronal excitation of the hypothalamus, 
likely lead to an increase in pituitary activation and the subsequent tendency of pituitary 
hypertrophy seen in SSu.   
The tendency for decreased GABAergic activity within the hippocampus as well as decreased 
pituitary mass is mirrored by pituitary ACTH production as seen in results of anterior 
pituitary analysis –known to be the primary site of ACTH production.  This concurs with 
literature, where the effects of hippocampal lesions as well as hippocampalectomies on 
ACTH levels were used to establish the role of the hippocampus in the regulation of the HPA 
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axis (Hershenson and Moos, 1986).  The reciprocal relationships seen between GABAergic 
function and ACTH production therefore suggests that decreased GABAergic output from the 
hippocampus, induced synergistically by restraint stress as well as S. frutescens 
administration, lead to an inverse ACTH production and release.   
Furthermore, stressed animals treated with S. frutescens tended to have an increased plasma 
ACTH concentration when compared to stressed animals treated with placebo (SP) (P = 
0.074).  These results coincide with the above-mentioned S. frutescens-mediated activation of 
the pituitary gland, and are likely the result of the same central neuronal activation.  The lack 
of significant increases in plasma ACTH levels seen in SP animals could be attributed to an 
intact corticosterone-mediated negative feedback loop as well as the relatively short half-life 
of ACTH in circulation. 
Adrenocortical ACTH levels seem to show an inverse gradient to circulating ACTH 
concentrations.  The lack of differences seen between group levels of adrenocortical IL-6 
could likely be attributed to the structural properties of the antibody used in IL-6 detection.  
Studies utilizing size exclusion chromatography and equilibrium centrifugation have shown 
that IL-6 binds to the soluble extracellular C-terminal domain of IL-6R (Ward et al., 1994).  
The antibody used to detect IL-6 was directed to bind the C-terminal as well, resulting in only 
free IL-6 being detected by the ABC staining.  Since IL-6 acts in an auto-/paracrine manner 
to stimulate glucocorticoid production (Arzt et al., 1998), it has its effects in close proximity 
from the point of release and free IL-6 would not give an accurate representation of the 
functional state of IL-6 in the adrenal cortex.   
The phenomenon of sympathetic GABAergic input has been observed in the splanchnic 
nerves originating from the spinal cord, innervating adrenal medulla and cortical cells since 
the late eighties (Peters et al., 1989).  It is therefore plausible to argue that acute 
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administration of GABA-rich S. frutescens leads to an over-activation of central and 
peripheral GABAAR, causing the functional shift mentioned earlier.  Even though the exact 
mechanisms are still unknown, the inhibition of adrenal corticosterone production in response 
to stress observed during chronic administration of S. frutescens could likely be attributed to 
a chronic GABAergic activation in the neuronal milieu. Autofluorescence, possibly due to 
faulty fixation, compromised the analysis of GABAAR in the adrenal gland.  Investigation of 
GABAAR in the adrenal gland could elucidate the degree of neuronal excitation and ergo 
sympathetic contribution to adrenocortical function.  This constitutes a potential avenue of 
investigation for future studies. 
Even though the raised plasma corticosterone levels did not differ between stressed rats 
treated with S. frutescens or placebo, plasma ACTH showed significant increases in stressed 
rats receiving S. frutescens.  (This evidence suggests that the HPA-axis was only sufficiently 
activated during a state of exacerbated sympathetic output from the hippocampus to the 
hypothalamus).  It seems that at a time point of one hour after the onset of an acute mild 
psychological stressor, the major stimulatory input to adrenocortical cells to produce and 
secrete corticosterone arises from sympathetic splanchnic nerves, as suggested in Chapter 3.   
These findings are in agreement with a vast body of literature.  The discrepancies between 
circulating plasma levels of ACTH and corticosterone have been apparent since the late 
fifties (Liddle et al., 1959).  It is only recently, however, that the sympatho-adrenal medullary 
system has been brought to the forefront of stress physiology.  Traditionally the HPA axis 
was thought to play the primary role in adrenocortical regulation (Plotsky et al., 1998).  This 
view has been challenged using modern retrograde fiber tracing techniques providing reports 
of splanchnic nerves terminating in the adrenal cortex (Kesse et al., 1988, Afework, 1989, 
Coupland et al., 1989).  Even though traditionally only the adrenal medulla was associated 
with innervations (Bornstein and Chrousos, 1999), evidence now suggests the presence of a 
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smaller quantity of branched neural fibers also distributed into the cortex (Parker et al., 
1993).   
Conducting the experiment during a reversed light/dark cycle led to an increase in basal and 
stressed corticosterone levels in the current study.  These increases are likely due to the rat’s 
circadian rhythm which increases corticosterone secretion during active times of the day.   
The importance of sympathetic regulation of the adrenal cortex, in the context of the acute 
stress response, is once again demonstrated by the lack of left adrenal hypertrophy found 
during a reverse light/dark cycle in the current study (restraint during dark).  The rationale 
behind the reversing of the light-dark cycle was to provide an awake state in rats (which are 
known to be nocturnal) during the conduction of the experimental protocol, thereby 
maximizing perception and awareness of the specific intervention.  Conducting the 
experiment during a reversed light/dark cycle led to an increase in basal and stressed 
corticosterone levels in the current study relative to the previous study performed (56 ± 33 
ng/ml vs. 7 ± 3 ng/ml).  These increases are likely due to differences between batches of rats 
or the rat’s circadian rhythm which increases corticosterone secretion during active times of 
the day.  The circadian regulation of adrenal glucocorticoid secretion has been well 
established in vertebrates (Bartter et al., 1956).  This diurnal cycle is characterized by 
persistence in the absence of stimuli and remains intact in blind patients (Landau and 
Feldman, 1954).  The sympathetic input to the adrenal gland has also been shown to be 
sensitive to photo-stimulation.  In rats, periods of darkness result in a dramatic increase in 
norepinephrine secretion from sympathetic nerves (Hashimoto, 1999).  Since norepinephrine 
is a powerful activator of the adrenal medulla chromaffin cells and subsequent cortical 
steroidogenesis, the lack of left adrenal hypertrophy seen in the results of the current study 
could be attributed to higher “background noise” produced by a increased basal drive of the 
sympathetic nervous system when compared to Chapter 3.  From this data, we can make the 
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following recommendation: a normal light/dark cycle (i.e. interventions during the light 
phase) is recommended for studies concerning the sympatho-adrenal medullary system. 
A statistically significant decrease in average adrenal mass was seen in S. frutescens-treated 
rats not exposed to stress. This effect of S. frutescens was attenuated in response to stress. In 
contrast to its effect on adrenal mass, S. frutescens lead to a tendency for circulating 
corticosterone concentrations to increase (96.4% in controls).  These seemingly opposing 
effects can be explained: the decrease in adrenal mass in controls may simply be the result of 
liposome depletion as a result of mildly increased corticosterone production known to occur 
in response to S. frutescens.  A decreased liposome content is indeed recognised as a 
histological indicator of the acute stress response (von Euler, 1967), as also discussed in 
Chapter 3. Furthermore, the metabolic effect of S. frutescens to increase the glucocorticoid 
levels is facilitated by its effect to decrease plasma glucose levels (Chadwick et al., 2007).  
This decrease in plasma glucose levels, in the presence of a relatively low level 
corticosterone environment, could lead to an increased demand for free fatty acids across the 
body, decreasing the bioavailability of free fatty acids to replenish liposome stores in the 
adrenal cortex, further contributing to the decreased adrenal mass reported.  The fact that 
adrenal mass did not decrease further in stressed animals, can be explained by the 
counteracting effects of substantial increases in corticosterone levels. Firstly, adrenal cortices 
would undergo large scale hypertrophy and/or hyperplasia in response to stress (as 
demonstrated in Chapter 3), adding to organ mass. Secondly, high levels of circulating 
corticosterone would have resulted in significantly increased gluconeogenesis, enabling more 
free fatty acids to replenish adrenal liposome stores. 
No significant variation in plasma testosterone levels were seen between groups, either after 
stress exposure, or S. frutescens administration.  Literature reports acute restraint stress 
leading to decreased plasma LH and testosterone assessed at various time points after stress 
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exposure, however these models likely induced a more severe psychological stress response 
(Sapolsky and Krey, 1988, Johnson et al., 1992, Norman and Smith, 1992).  The lack of 
significant variation seen in testosterone levels in response to S. frutescens administration 
suggests that no androgen-related side effects would be encountered during the clinical 
application of S. frutescens. 
This exacerbated stress response, likely due to the tendency of GABAAR to decrease in SSu, 
caused the activation of both the HPA-axis and the sympatho-adrenal medullary system (Fig. 
4.10).  It is noteworthy that even though no differences were seen in plasma corticosterone 
levels between stress groups receiving placebo and those receiving S. frutescens, plasma as 
well as pituitary ACTH levels only increased significantly rats treated with S. frutescens.  We 
can therefore assume that the ACTH-mediated HPA-axis was only sufficiently activated 
during the exacerbated stress response and that glucocorticoid regulation in a typical 
psychological stress response would be primarily under the control of the sympatho-adrenal 
medullary system.   
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Figure 4.9. Schematic representation of the pathways involved in stress signal transduction 90 minutes 
after S. frutescens administration with blue indicating activated pathways. 
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Chapter 5 
Conclusion 
From data presented in Chapter 3, we can conclude that IL-6 plays an important role in the 
sympatho-adrenal medullary system, and that blocking this pathway effectively attenuates the 
corticosterone response to acute psychological stress.  Taken together, these results suggest 
that in the immediate response to acute stress, the stimulatory effect on the adrenal cortex to 
initiate glucocorticoid release is under direct neural control, facilitated through the sympatho-
adrenal medullary system. Furthermore, the data suggest that the systemic endocrine signal 
produced by the HPA-axis is an alternative pathway for glucocorticoid release initiated 
somewhat later in the response to stress.  We can therefore accept our first hypothesis. 
Furthermore, the phenomenon of afterdischarge, brought on by the combination of stress and 
S. frutescens administration, has significant implications for stress-relief treatment strategies 
involving acute administration of GABA.  Data presented in Chapter 4 demonstrated that 
acute S. frutescens-administration lead to a tendency for decreased inhibitory output of the 
hippocampus, creating an augmented stress response that was sufficient to activate both the 
sympatho-adrenal medullary system as well as the secondary HPA-axis.  Given this result, 
we conclude that the anxiolytic effects of S. frutescens anecdotally reported in humans is 
most likely dependent on activation of the mesolimbic dopaminergic reward pathway. 
Furthermore, given previous reports of an effect of S. frutescens to partially inhibit 
steroidogenesis at adrenal level, we conclude that in our model, time point of sacrifice was 
probably too early to illustrate these proven effects at peripheral target tissue level. We 
therefore reject our second hypothesis, since acute S. frutescens-administration did not show 
any central anxiolytic effects.  
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In terms of the potential use of S. frutescens as clinical anxiolytic treatment, we have some 
reservations. Although there is convincing evidence in the literature suggesting a beneficial 
effect of chronic treatment, acute treatment actually aggravated the stress response in our 
model. Although we acknowledge that this increased stress response may have been an 
“artifact” of having an animal model, one cannot disregard the possibility of a similar effect 
in humans. Therefore, our recommendation is that clinical studies be performed in humans, 
so that the central responses can also be assessed subjectively, e.g. by questionnaire. This 
should be done in combination of personality classifications, to more clearly define which 
populations may in fact benefit from S. frutescens treatment, and which may show a negative 
reaction to treatment, which could manifest as feelings of paranoia and anxiety, and in fact 
exacerbate the pre-existing pathology or stress status.   
Lastly, future studies investigating shifts in GABAergic activity within the adrenal glands 
and amygdala after exposure to restraint stress and/or acute S. frutescens administration could 
further elucidate the excitatory vs. inhibitory effects of S. frutescens treatment.   
 
 
 
 
 
 
 
80 
 
References 
Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, 
Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory 
neurons prevents cell death. Nature 374:450-453. 
Aderka D, Le JM, Vilcek J (1989) IL-6 inhibits lipopolysaccharide-induced tumor necrosis 
factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 
143:3517-3523. 
Afework M (1989) The sensory innervation of the rat adrenal gland., vol. M. Phil  
Nottingham: University of Nottingham. 
Arbo A, Mancilla J, Alpuche C, Santos JI (1990) In vitro and in vivo effects of 
subinhibitory concentrations of clindamycin on experimental Klebsiella pneumoniae 
sepsis. Chemotherapy 36:337-344. 
Arzt E, Paez Pereda M, Costas M, Sauer J, Renner U, Holsboer F, Stalla GK (1998) 
Cytokine expression and molecular mechanisms of their auto/paracrine regulation of 
anterior pituitary function and growth. Ann N Y Acad Sci 840:525-531. 
Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, Calandra T, Gemsa 
D, Donnelly T, Atkins RC, Bucala R (1997) Migration inhibitory factor expression 
in experimentally induced endotoxemia. Am J Pathol 150:235-246. 
Barbaccia ML, Roscetti G, Trabucchi M, Mostallino MC, Concas A, Purdy RH, Biggio 
G (1996) Time-dependent changes in rat brain neuroactive steroid concentrations and 
GABAA receptor function after acute stress. Neuroendocrinology 63:166-172. 
Bartalena L, Hammond GL, Farsetti A, Flink IL, Robbins J (1993) Interleukin-6 inhibits 
corticosteroid-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) 
cells. Endocrinology 133:291-296. 
Barton BE, Jackson JV (1993) Protective role of interleukin 6 in the lipopolysaccharide-
galactosamine septic shock model. Infect Immun 61:1496-1499. 
81 
 
Bartter FC, Duncan LE, Jr., Liddle GW (1956) Dual mechanism regulating adrenocortical 
function in man. Am J Med 21:380-386. 
Bayoumi RA, Kirwan JR, Smith WR (1972) Some effects of dietary vitamin B 6 
deficiency and 4-deoxypyridoxine on -aminobutyric acid metabolism in rat brain. J 
Neurochem 19:569-576. 
Bents H (1985) Psychology of male infertility--a literature survey. Int J Androl 8:325-336. 
Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 
22:123-131. 
Black PH, Garbutt LD (2002) Stress, inflammation and cardiovascular disease. J 
Psychosom Res 52:1-23. 
Blake JA, Richardson JE, Bult CJ, Kadin JA, Eppig JT (2003) MGD: the Mouse Genome 
Database. Nucl Acids Res 31:193-195. 
Bormann J (2000) The 'ABC' of GABA receptors. Trends Pharmacol Sci 21:16-19. 
Bornstein SR, Chrousos GP (1999) Clinical review 104: Adrenocorticotropin (ACTH)- and 
non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J 
Clin Endocrinol Metab 84:1729-1736. 
Bornstein SR, Ehrhart-Bornstein M, Guse-Behling H, Scherbaum WA (1992) Structure 
and dynamics of adrenal mitochondria following stimulation with corticotropin 
releasing hormone. Anat Rec 234:255-262. 
Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum 
WA (1994) Intimate contact of chromaffin and cortical cells within the human adrenal 
gland forms the cellular basis for important intraadrenal interactions. J Clin 
Endocrinol Metab 78:225-232. 
Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, 
Enna SJ (2002) International Union of Pharmacology. XXXIII. Mammalian gamma-
aminobutyric acid(B) receptors: structure and function. Pharmacol Rev 54:247-264. 
82 
 
Brummerhoff SWD (1969) Some constituents of Sutherlandia microphylla. vol. D.Sc  
Bloemfontein: University of Free State. 
Caamano CA, Morano MI, Akil H (2001) Corticosteroid receptors: a dynamic interplay 
between protein folding and homeostatic control. Possible implications in psychiatric 
disorders. Psychopharmacol Bull 35:6-23. 
Cameron HA, Gould E (1996) Distinct populations of cells in the adult dentate gyrus 
undergo mitosis or apoptosis in response to adrenalectomy. J Comp Neurol 369:56-
63. 
Campeau S, Watson SJ (1997) Neuroendocrine and behavioral responses and brain pattern 
of c-fos induction associated with audiogenic stress. J Neuroendocrinol 9:577-588. 
Cannon (1929) Organization of physiological homeostasis. Physiol Rev 9:399-431. 
Carmichael SW, Stoddard SL, O'Connor DT, Yaksh TL, Tyce GM (1990) The secretion 
of catecholamines, chromogranin A and neuropeptide Y from the adrenal medulla of 
the cat via the adrenolumbar vein and thoracic duct: different anatomic routes based 
on size. Neuroscience 34:433-440. 
Carter R (2009) The Brain Book. New York: Dorling Kindersley. 
Chadwick WA, Roux S, van de Venter M, Louw J, Oelofsen W (2007) Anti-diabetic 
effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet. J 
Ethnopharmacol 109:121-127. 
Chebib M, Johnston GA (2000) GABA-Activated ligand gated ion channels: medicinal 
chemistry and molecular biology. J Med Chem 43:1427-1447. 
Chessler SD, Simonson WT, Sweet IR, Hammerle LP (2002) Expression of the vesicular 
inhibitory amino acid transporter in pancreatic islet cells: distribution of the 
transporter within rat islets. Diabetes 51:1763-1771. 
Chrousos GP, Gold PW (1992) The Concepts of Stress and Stress System Disorders. JAMA 
267(9):1244-1252. 
 
83 
 
Collu R, Gibb W, Ducharme JR (1984) Effects of stress on the gonadal function. J 
Endocrinol Invest 7:529-537. 
Conrad CD, Galea LA, Kuroda Y, McEwen BS (1996) Chronic stress impairs rat spatial 
memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav 
Neurosci 110:1321-1334. 
Conrad CD, Jackson JL, Wieczorek L, Baran SE, Harman JS, Wright RL, Korol DL 
(2004) Acute stress impairs spatial memory in male but not female rats: influence of 
estrous cycle. Pharmacol Biochem Behav 78:569-579. 
Coupland RE (1965) Electron microscopic observations on the structure of the rat adrenal 
medulla: II. Normal innervation. J Anat 99:255-272. 
Coupland RE, Parker TL, Kesse WK, Mohamed AA (1989) The innervation of the 
adrenal gland. III. Vagal innervation. J Anat 163:173-181. 
Cullinan WE, Helmreich DL, Watson SJ (1996) Fos expression in forebrain afferents to 
the hypothalamic paraventricular nucleus following swim stress. J Comp Neurol 
368:88-99. 
Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ (1995) Pattern and time 
course of immediate early gene expression in rat brain following acute stress. 
Neuroscience 64:477-505. 
Cullinan WE, Herman JP, Watson SJ (1993) Ventral subicular interaction with the 
hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the 
stria terminalis. J Comp Neurol 332:1-20. 
Dallman MF, Engeland WC, Shinsako J (1976) Compensatory adrenal growth: a neurally 
mediated reflex. Am J Physiol 231:408-414. 
Dayanithi G, Antoni FA (1989) Rapid as well as delayed inhibitory effects of glucocorticoid 
hormones on pituitary adrenocorticotropic hormone release are mediated by type II 
glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as 
well as protein. Endocrinology 125:308-313. 
84 
 
de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998a) Glucocorticoid Feedback 
Resistance Trends Endocrinol Metab 8:26-33. 
de Kloet ER, Vreugdenhil E, Oitzl MS, Joels MJ (1998b) Brain corticosteroid receptor 
balance in health and disease. Endocr Rev 19:269-301. 
DeRijk RH, Boelen A, Tilders FJ, Berkenbosch F (1994) Induction of plasma interleukin-6 
by circulating adrenaline in the rat. Psychoneuroendocrinology 19:155-163. 
Dhabhar FS, McEwen BS (1999) Enhancing versus suppressive effects of stress hormones 
on skin immune function. Proc Natl Acad Sci U S A 96:1059-1064. 
Di S, Malcher-Lopes R, Halmos KC, Tasker JG (2003) Nongenomic glucocorticoid 
inhibition via endocannabinoid release in the hypothalamus: a fast feedback 
mechanism. J Neurosci 23:4850-4857. 
Di S, Malcher-Lopes R, Marcheselli VL, Bazan NG, Tasker JG (2005) Rapid 
glucocorticoid-mediated endocannabinoid release and opposing regulation of 
glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular 
neurons. Endocrinology 146:4292-4301. 
Di S, Tasker JG (2008) Rapid synapse-specific regulation of hypothalamic magnocellular 
neurons by glucocorticoids. Prog Brain Res 170:379-388. 
Di Santo E, Alonzi T, Poli V, Fattori E, Toniatti C, Sironi M, Ricciardi-Castagnoli P, 
Ghezzi P (1997) Differential effects of IL-6 on systemic and central production of 
TNF: a study with IL-6-deficient mice. Cytokine 9:300-306. 
Dronjak S, Gavrilovic L, Filipovic D, Radojcic MB (2004) Immobilization and cold stress 
affect sympatho-adrenomedullary system and pituitary-adrenocortical axis of rats 
exposed to long-term isolation and crowding. Physiol Behav 81:409-415. 
Eastman R (2005) Epilepsy in South Africa. Acta Neurologica Scandinavica Supplementary 
181. 
Ehrhart-Bornstein M, Bornstein SR, Gonzalez-Hernandez J, Holst JJ, Waterman MR, 
Scherbaum WA (1995) Sympathoadrenal regulation of adrenocortical 
steroidogenesis. Endocr Res 21:13-24. 
85 
 
Ehrhart-Bornstein M, Bornstein SR, Guse-Behling H, Stromeyer HG, Rasmussen TN, 
Scherbaum WA, Adler G, Holst JJ (1994) Sympathoadrenal regulation of adrenal 
androstenedione release. Neuroendocrinology 59:406-412. 
Ehrhart-Bornstein M, Bornstein SR, Scherbaum WA, Pfeiffer EF, Holst JJ (1991) Role 
of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal 
cortex. Neuroendocrinology 54:623-628. 
Elenkov IJ, Chrousos GP (1999a) Stress Hormones, Th1/Th2 patterns, Pro/Anti-
inflammatory Cytokines and Susceptibility to Disease. Trends Endocrinol Metab 
10:359-368. 
Elenkov IJ, Chrousos GP (1999b) Stress, cytokine patterns and susceptibility to disease. 
Baillieres Best Pract Res Clin Endocrinol Metab 13:583-595. 
Enna SJ, Snyder SH (1975) Properties of γ-aminobutyric acid (GABA) receptor binding in 
rat brain synaptic membrane fractions Brain Res 100:81-87. 
Essential_Survival (2010) Essential Survival. http://www.essentialsurvival.org/sniff-
problems-away. (Date accessed: 8/12/2010). 
Ferraguti F, Zoli M, Aronsson M, Agnati LF, Goldstein M, Filer D, Fuxe K (1990) 
Distribution of glutamic acid decarboxylase messenger RNA-containing nerve cell 
populations of the male rat brain. J Chem Neuroanat 3:377-396. 
Filiopoulos V, Vlassopoulos D (2009) Inflammatory syndrome in chronic kidney disease: 
pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets 8:369-382. 
Fortak W, Kmiec B (1968) [On the occurrence of chromophilic cells in the adrenal cortex of 
white rats]. Endokrynol Pol 19:117-128. 
Foster RH, MacFarlane CH, Bustamante MO (1997) Recent progress in understanding 
aldosterone secretion. Gen Pharmacol 28:647-651. 
Franchimont D, Bouma G, Galon J, Wolkersdorfer GW, Haidan A, Chrousos GP, 
Bornstein SR (2000a) Adrenal cortical activation in murine colitis. Gastroenterology 
119:1560-1568. 
86 
 
Franchimont N, Rydziel S, Canalis E (2000b) Transforming growth factor-beta increases 
interleukin-6 transcripts in osteoblasts. Bone 26:249-253. 
Fujiwara-Tsukamoto Y, Isomura Y, Nambu A, Takada M (2003) Excitatory GABA input 
directly drives seizure-like rhythmic synchronization in mature hippocampal CA1 
pyramidal cells. Neuroscience 119:265-275. 
Funder JW (1986) Adrenocorticoid receptors in the brain. In: Frontiers in 
Neuroendocrinology(Ganong, W. F. and Martini, L., eds), pp 169-189 New York: 
Raven Press. 
Gadient RA, Lachmund A, Unsicker K, Otten U (1995) Expression of interleukin-6 (IL-6) 
and IL-6 receptor mRNAs in rat adrenal medulla. Neurosci Lett 194:17-20. 
Gallo-Payet N, Pothier P, Isler H (1987) On the presence of chromaffin cells in the adrenal 
cortex: their possible role in adrenocortical function. Biochem Cell Biol 65:588-592. 
Gamel-Didelon K, Kunz L, Fohr KJ, Gratzl M, Mayerhofer A (2003) Molecular and 
physiological evidence for functional gamma-aminobutyric acid (GABA)-C receptors 
in growth hormone-secreting cells. J Biol Chem 278:20192-20195. 
Gao HB, Shan LX, Monder C, Hardy MP (1996) Suppression of endogenous 
corticosterone levels in vivo increases the steroidogenic capacity of purified rat 
Leydig cells in vitro. Endocrinology 137:1714-1718. 
Giblin PT, Poland ML, Moghissi KS, Ager JW, Olson JM (1988) Effects of stress and 
characteristic adaptability on semen quality in healthy men. Fertil Steril 49:127-132. 
Goebel MU, Mills PJ, Irwin MR, Ziegler MG (2000) Interleukin-6 and tumor necrosis 
factor-alpha production after acute psychological stress, exercise, and infused 
isoproterenol: differential effects and pathways. Psychosom Med 62:591-598. 
Goldstein DS (1995) Stress resonse patterns. In: Stress, catecholamines, and cardiovascular 
disease(Goldstein, D. S., ed), pp 287-328 New York: Oxford University Press. 
Goldstein DS, McEwen B (2002) Allostasis, homeostats, and the nature of stress. Stress 
5:55-58. 
87 
 
Goleman D (1996) Emotional Intelligence: Why It Can Matter More Than IQ. New York: 
Bantam Books. 
Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Spath-Schwalbe E, Scherbaum WA, 
Bornstein SR (1996) Human adrenal cells express tumor necrosis factor-alpha 
messenger ribonucleic acid: evidence for paracrine control of adrenal function. J Clin 
Endocrinol Metab 81:807-813. 
Gonzalez-Quijano MI, Ariznavarreta C, Martin AI, Treguerres JA, Lopez-Calderon A 
(1991) Naltrexone does not reverse the inhibitory effect of chronic restraint on 
gonadotropin secretion in the intact male rat. Neuroendocrinology 54:447-453. 
Goodman LS, Gilman A, Brunton LL, Lazo JS, Parker KL (2006) Goodman & Gilman's 
The pharmacological basis of therapeutics. NY: McGraw-Hill. 
Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E (1997) Neurogenesis in the dentate 
gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor 
activation. J Neurosci 17:2492-2498. 
Gruen RJ, Wenberg K, Elahi R, Friedhoff AJ (1995) Alterations in GABAA receptor 
binding in the prefrontal cortex following exposure to chronic stress. Brain Res 
684:112-114. 
Guse-Behling H, Ehrhart-Bornstein M, Bornstein SR, Waterman MR, Scherbaum WA, 
Adler G (1992) Regulation of adrenal steroidogenesis by adrenaline: expression of 
cytochrome P450 genes. J Endocrinol 135:229-237. 
Hatch A, Balazs T, Wiberg GS, Grice HC (1963) Long-term isolation stress in rats. science 
142:507. 
Heila H, Iaomwra ET, Henriksen MM, Heikkinen ME, Marttunen MJ, Lonnqvist JK 
(1997) Suicide and schizophrenia: a nationwide psychological autopsy study on age- 
and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. 
American Journal of Psychiatry 154:1235-1242. 
Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of the 
hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84. 
88 
 
Herman JP, Cullinan WE, Watson SJ (1994) Involvement of the bed nucleus of the stria 
terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA 
expression. J Neuroendocrinol 6:433-442. 
Herman JP, Cullinan WE, Young EA, Akil H, Watson SJ (1992) Selective forebrain fiber 
tract lesions implicate ventral hippocampal structures in tonic regulation of 
paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP) mRNA expression. Brain Res 592:228-238. 
Herman JP, Ostrander MM, Mueller NK, Figueiredo H (2005) Limbic system 
mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog 
Neuropsychopharmacol Biol Psychiatry 29:1201-1213. 
Herman JP, Prewitt CM, Cullinan WE (1996) Neuronal circuit regulation of the 
hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol 10:371-394. 
Herman JP, Schafer KH, Sladek CD, Day R, Young EA, Akil H, Watson SJ (1989) 
Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP 
mRNA in select populations of neuroendocrine neurons. Brain Res 501:235-246. 
Hershenson FM, Moos WH (1986) Drug development for senile cognitive decline. J Med 
Chem 29:1125-1130. 
Hess JL, Denenberg VH, Zarrow MX, Pheifer WD (1968) Modification of the 
corticosterone response curve as a function of handling in infancy. In: Psychology and 
biological sciences Indiana, U.S.A: Purdue University. 
Hillhouse EW, Milton NG (1989) Effect of noradrenaline and gamma-aminobutyric acid on 
the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the 
rat hypothalamus in vitro. J Endocrinol 122:719-723. 
Hinz B, Hirschelmann R (2000) Rapid non-genomic feedback effects of glucocorticoids on 
CRF-induced ACTH secretion in rats. Pharm Res 17:1273-1277. 
Hoffman AF, Lupica CR (2000) Mechanisms of cannabinoid inhibition of GABA(A) 
synaptic transmission in the hippocampus. J Neurosci 20:2470-2479. 
89 
 
Hoheisel G, Schauer J, Scherbaum WA, Bornstein SR (1998) The effect of corticotropin-
releasing hormone (CRH) on the adrenal medulla in hypophysectomized rats. Histol 
Histopathol 13:81-87. 
Hollinshead WH (1937) The innervation of abdominal chromaffin tissue. Journal of 
comparative neurology 67:133-143. 
Huang Z, Zang K, Reichardt LF (2005) The origin recognition core complex regulates 
dendrite and spine development in postmitotic neurons. J Cell Biol 170:527-535. 
Isomura Y, Fujiwara-Tsukamoto Y, Takada M (2003) Glutamatergic propagation of 
GABAergic seizure-like afterdischarge in the hippocampus in vitro. J Neurophysiol 
90:2746-2751. 
Jacobson L, Sapolsky R (1991) The Role of the Hippocampus in Feedback Regulation of 
the Hypothalamic-Pituitary-Adrenocortical Axis. Endocr Rev 12:118-134. 
Jang IS, Jeong HJ, Akaike N (2001) Contribution of the Na-K-Cl cotransporter on 
GABA(A) receptor-mediated presynaptic depolarization in excitatory nerve terminals. 
J Neurosci 21:5962-5972. 
Jankord R, Turk JR, Schadt JC, Casati J, Ganjam VK, Price EM, Keisler DH, 
Laughlin MH (2007) Sex difference in link between interleukin-6 and stress. 
Endocrinology 148:3758-3764. 
John CD, Buckingham JC (2003) Cytokines: regulation of the hypothalamo-pituitary-
adrenocortical axis. Curr Opin Pharmacol 3:78-84. 
Johnson EO, Kamilaris TC, Chrousos GP, Gold PW (1992) Mechanisms of stress: a 
dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev 
16:115-130. 
Johnston GA (2005) GABA(A) receptor channel pharmacology. Curr Pharm Des 11:1867-
1885. 
Judd AM (1998) Cytokine expression in the rat adrenal cortex. Horm Metab Res 30:404-
410. 
90 
 
Kaplan JT, Freedman J, Iacoboni M (2007) Us versus them: Political attitudes and party 
affiliation influence neural response to faces of presidential candidates. 
Neuropsychologia 7:55-64. 
Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) 
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the 
control of GABAergic transmission. J Neurosci 21:9506-9518. 
Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF (1999) 
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon 
terminals of specific hippocampal interneurons. J Neurosci 19:4544-4558. 
Katzung BG (2004) Basic and clinical pharmacology. NY: McGraw-Hill. 
Keller-Wood ME, Dallman MF (1984) Corticosteroid inhibition of ACTH secretion. 
Endocr Rev 5:1-24. 
Kesse WF, Parker TL, Coupland RE (1988) The innervation of the adrenal gland. I. The 
source of pre- and postganglionic nerve fibres to te rat adrenal gland. J Anat 157:33-
41. 
Kitay JI (1961) Sex differences in adrenal cortical secretion in the rat. Endocrinology 
68:818-824. 
Kuriyama K, Sze PY (1971) Blood-brain barrier to H3-gamma-aminobutyric acid in normal 
and amino oxyacetic acid-treated animals. Neuropharmacology 10:103-108. 
Landau J, Feldman S (1954) Diminished endogenous morning eosinopenia in blind 
subjects. Acta Endocrinol (Copenh) 15:53-60. 
Le Novere N, Changeux J-P (2001) The ligand-gated ion channel database. Nucl Acids Res 
29:294-295. 
Levy B, Valtier M, deChillou C, Bollaert PE, Cane D, Mallie JP (1999) Beneficial effects 
of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate 
metabolism and muscle high energy phosphates during endotoxic shock in rats. Shock 
11:98-103. 
91 
 
Li HY, Ericsson A, Sawchenko PE (1996) Distinct mechanisms underlie activation of 
hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents 
in categorically different stress paradigms. Proc Natl Acad Sci U S A 93:2359-2364. 
Liddle GW, Estep HL, Kendall JW, Jr., Williams WC, Jr., Townes AW (1959) Clinical 
application of a new test of pituitary reserve. J Clin Endocrinol Metab 19:875-894. 
Lopez JF, Akil H, Watson SJ (1999) Neural circuits mediating stress. Biol Psychiatry 
46:1461-1471. 
Losada ME (1988) Changes in the central GABAergic system after acute treatment with 
corticosterone. Naunyn Schmiedebergs Arch Pharmacol 337:669-674. 
Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas AZ (2004) Striatin 
assembles a membrane signalling complex necessary for rapid, nongenomic activation 
of endothelial NO synthase by estrogen receptor alpha. Ploc Natl Acad Sci 
101:17126-17131. 
Lyson K, McCann SM (1991) The effect of interleukin-6 on pituitary hormone release in 
vivo and in vitro. Neuroendocrinology 54:262-266. 
Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, 
Benoy I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS (1998) The effects of 
psychological stress on humans: increased production of pro-inflammatory cytokines 
and a Th1-like response in stress-induced anxiety. Cytokine 10:313-318. 
Magarinos AM, McEwen BS, Flugge G, Fuchs E (1996) Chronic psychosocial stress 
causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in 
subordinate tree shrews. J Neurosci 16:3534-3540. 
Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone 
metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004-
1007. 
Malcher-Lopes R, Di S, Marcheselli VS, Weng FJ, Stuart CT, Bazan NG, Tasker JG 
(2006) Opposing crosstalk between leptin and glucocorticoids rapidly modulates 
synaptic excitation via endocannabinoid release. J Neurosci 26:6643-6650. 
92 
 
Malcher-Lopes R, Franco A, Tasker JG (2008) Glucocorticoids shift arachidonic acid 
metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory 
switch. Eur J Pharmacol 583:322-339. 
Mao CC, Peralta E, Morini F, Costa E (1978) The turnover rate of gamma-aminobutyric 
acid in the substantia nigra following electrical stimulation or lesioning of the 
strionigral pathways. Brain Res 155:147-152. 
Marby D, Lockhart GR, Raymond R, Linakis JG (2001) Anti-interleukin-6 antibodies 
attenuate inflammation in a rat meningitis model. Acad Emerg Med 8:946-949. 
Marx C, Ehrhart-Bornstein M, Scherbaum WA, Bornstein SR (1998) Regulation of 
adrenocortical function by cytokines--relevance for immune-endocrine interaction. 
Horm Metab Res 30:416-420. 
Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the 
hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77:1690-
1694. 
Matta SG, Weatherbee J, Sharp BM (1992) A central mechanism is involved in the 
secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-
1 beta. Neuroendocrinology 56:516-525. 
McEwen BS (1999) Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-122. 
McEwen BS, Sapolsky RM (1995) Stress and cognitive function. Curr Opin Neurobiol 
5:205-216. 
McEwen BS, Seeman T (1999) Protective and damaging effects of mediators of stress. 
Elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad 
Sci 896:30-47. 
McKittrick CR, Magarinos AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR 
(2000) Chronic social stress reduces dendritic arbors in CA3 of hippocampus and 
decreases binding to serotonin transporter sites. Synapse 36:85-94. 
93 
 
Mendel I, Katz A, Kozak N, Ben-Nun A, Revel M (1998) Interleukin-6 functions in 
autoimmune encephalomyelitis: a study in gene-targeted mice. Eur J Immunol 
28:1727-1737. 
Metzeler K, Agoston A, Gratzl M (2004) An Intrinsic gamma-aminobutyric acid 
(GABA)ergic system in the adrenal cortex: findings from human and rat adrenal 
glands and the NCI-H295R cell line. Endocrinology 145:2402-2411. 
Miller GE, Rohleder N, Stetler C, Kirschbaum C (2005) Clinical depression and 
regulation of the inflammatory response during acute stress. Psychosom Med 67:679-
687. 
Millhorn DE, Eldridge FL, Waldrop TG (1980) Prolonged stimulation of respiration by a 
new central neural mechanism. Respir Physiol 41:87-103. 
Mishunina TM, Kononenko VY (2002) Specific GABA binding in the adrenals and blood 
corticosteroid levels in stress in intact rats and rats with changes in the functional 
activity of the hypothalamo-pituitary-adrenal system. Neurosci Behav Physiol 32:109-
112. 
Moghissi KS, Wallach EE (1983) Unexplained infertility. Fertil Steril 39:5-21. 
Monder C, Miroff Y, Marandici A, Hardy MP (1994) 11 beta-Hydroxysteroid 
dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat 
Leydig cells. Endocrinology 134:1199-1204. 
Morris K (2001) Treating HIV in South Africa-a tale of two systems. Lancet 357:1190. 
Moshe D (1998) A biosystematic study of the genus Sutherlandia R.Br (Fabaceae, 
Galegeae). In: Botany, vol. M.Sc  Johannesburg: University of Johannesburg. 
Myerhofer A, Hohne-Zell B, Gamel-Didelon K, Jung H, Redecker P, Grube D, 
Urbanski HF, Gasnier B, Fritschy JN, Gratzl M (2001) Gamma-aminobutyric acid 
(GABA): a para- and/or autocrine hormone in the pituitary. Faseb J 15:1089-1091. 
Nestler EJ, Carlezon WA, Jr. (2006) The mesolimbic dopamine reward circuit in 
depression. Biol Psychiatry 59:1151-1159. 
94 
 
Nittoh T, Fujimori H, Kozumi Y, Ishihara K, Mue S, Ohuchi K (1998) Effects of 
glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. Eur J 
Pharmacol 354:73-81. 
Norman RL, Smith CJ (1992) Restraint inhibits luteinizing hormone and testosterone 
secretion in intact male rhesus macaques: effects of concurrent naloxone 
administration. Neuroendocrinology 55:405-415. 
Nukina H, Sudo N, Komaki G, Yu X, Mine K, Kubo C (1998a) The restraint stress-
induced elevation in plasma interleukin-6 negatively regulates the plasma TNF-alpha 
level. Neuroimmunomodulation 5:323-327. 
Nukina H, Sudo N, Komaki G, Yu X, Mine K, Kubo C (1998b) The restraint stress-
induced elevation in plasma interleukin-6 negatively regulates the plasma TNF-alpha 
level. Neuroimmunomodulation 5:323-327. 
Nussdorfer GG, Gottardo G (1998) Neuropeptide-Y family of peptides in the autocrine-
paracrine regulation of adrenocortical function. Horm Metab Res 30:368-373. 
Ojewole JA (2008) Anticonvulsant property of Sutherlandia frutescens R. BR. (variety 
Incana E. MEY.) [Fabaceae] shoot aqueous extract. Brain Res Bull 75:126-132. 
Olsen RW, DeLorey TM (1999) GABA and Glycine. In: Basic Neurochemistry: Molecular, 
Cellular and Medical Aspects(Siegel, G. J. et al., eds) Philadelphia: Lippincott-Raven. 
Omrani GR, Rosner W, Loeb JN (1980) Induction of hepatic tyrosine aminotransferase by 
physiological stress: relation to endogenous glucocorticoid secretion and cytosol 
receptor depletion. J Steroid Biochem 13:719-722. 
Pacak K, Palkovits M, Yadid G, Kvetnansky R, Kopin IJ, Goldstein DS (1998) 
Heterogeneous neurochemical responses to different stressors: a test of Selye's 
doctrine of nonspecificity. Am J Physiol 275:R1247-1255. 
Panzer S, Madden M, Matsuki K (1993) Interaction of IL-1 beta, IL-6 and tumour necrosis 
factor-alpha (TNF-alpha) in human T cells activated by murine antigens. Clin Exp 
Immunol 93:471-478. 
95 
 
Parker TL, Kesse WK, Mohamed AA, Afework M (1993) The innervation of the 
mammalian adrenal gland. J Anat 183 ( Pt 2):265-276. 
Patapoutian A, Reichardt LF (2001) Trk receptors: mediators of neurotrophin action. Curr 
Opin Neurobiol 11:272-280. 
Path G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA (1997) Interleukin-6 and 
the interleukin-6 receptor in the human adrenal gland: expression and effects on 
steroidogenesis. J Clin Endocrinol Metab 82:2343-2349. 
Path G, Bornstein SR, Spath-Schwalbe E, Scherbaum WA (1996) Direct effects of 
interleukin-6 on human adrenal cells. EndocrRes 22:867-873. 
Pavlides C, Kimura A, Magarinos AM, McEwen BS (1994) Type I adrenal steroid 
receptors prolong hippocampal long-term potentiation. Neuroreport 5:2673-2677. 
Pavlides C, Ogawa S, Kimura A, McEwen BS (1996) Role of adrenal steroid 
mineralocorticoid and glucocorticoid receptors in long-term potentiation in the CA1 
field of hippocampal slices. Brain Res 738:229-235. 
Pavlides C, Watanabe Y, Magarinos AM, McEwen BS (1995) Opposing roles of type I 
and type II adrenal steroid receptors in hippocampal long-term potentiation. 
Neuroscience 68:387-394. 
Payne AH, O'Shaughnessy PJ (1996) Structure, function and regulation of steroidogenic 
enzymes in the Leydig cell. In: The Leydig Cell(Payne, A. H. et al., eds), pp 259-286 
Vienna: Cache River Press. 
Pedersen BK, Fischer CP (2007) Physiological roles of muscle-derived interleukin-6 in 
response to exercise. Curr Opin Clin Nutr Metab Care 10:265-271. 
Pelto-Huikko M, Salminen T, Hervonen A (1985) Localization of enkephalins in 
adrenaline cells and the nerves innervating adrenaline cells in rat adrenal medulla. 
Histochemistry 82:377-383. 
Peters JA, Lambert JJ, Cottrell GA (1989) An electrophysiological investigation of the 
characteristics and function of GABAA receptors on bovine adrenomedullary 
chromaffin cells. Pflugers Arch 415:95-103. 
96 
 
Pitman DL, Ottenweller JE, Natelson BH (1988) Plasma corticosterone levels during 
repeated presentation of two intensities of restraint stress: chronic stress and 
habituation. Physiol Behav 43:47-55. 
Plotsky PM, Owens MJ, Nemeroff CB (1998) Psychoneuroendocrinology of depression. 
Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 21:293-307. 
Prevoo D, Smith C, Swart P, Swart AC (2004) The effect of Sutherlandia frutescens on 
steroidogenesis: confirming indigenous wisdom. Endocr Res 30:745-751. 
Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the 
pathogenesis of depression. Trends Immunol 27:24-31. 
Rasia-Filho AA, Londero RG, Achaval M (2000) Functional activities of the amygdala: an 
overview. J Psychiatry Neurosci 25:14-23. 
Remes K, Kuoppasalmi K, Adlercreutz H (1985) Effect of physical exercise and sleep 
deprivation on plasma androgen levels: modifying effect of physical fitness. Int J 
Sports Med 6:131-135. 
Retana-Marquez S, Bonilla-Jaime H, Vazquez-Palacios G, Martinez-Garcia R, 
Velazquez-Moctezuma J (2003) Changes in masculine sexual behavior, 
corticosterone and testosterone in response to acute and chronic stress in male rats. 
Horm Behav 44:327-337. 
Robinson PM, Perry RA, Hardy KJ, Coghlan JP, Scoggins BA (1977) The innervation of 
the adrenal cortex in the sheep, Ovis ovis. J Anat 124:117-129. 
Sainio EL, Lehtola T, Roininen P (1988) Radioimmunoassay of total and free 
corticosterone in rat plasma: measurement of the effect of different doses of 
corticosterone. Steroids 51:609-622. 
Sapolsky RM, Krey LC (1988) Stress-induced suppression of luteinizing hormone 
concentrations in wild baboons: role of opiates. J Clin Endocrinol Metab 66:722-726. 
Sapolsky RM, Krey LC, McEwen BS (1984) Glucocorticoid-sensitive hippocampal 
neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad 
Sci U S A 81:6174-6177. 
97 
 
Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E (1998) Downregulation of BDNF 
mRNA and protein in the rat hippocampus by corticosterone. Brain Res 813:112-120. 
Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA (1990) 
Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and 
tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 
and TNF. Blood 75:40-47. 
Schleimer RP, Bochner BS (1994) The effects of glucocorticoids on human eosinophils. J 
Allergy Clin Immunol 94:1202-1213. 
Seckl JR, Walker BR (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a 
tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371-1376. 
Segerstrom SC, Miller GE (2004) Psychological stress and the human immune system: a 
meta-analytic study of 30 years of inquiry. Psychol Bull 130:601-630. 
Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto 
H (1998) Apoptosis of lymphocytes induced by glucocorticoids and relationship to 
therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 
41:823-830. 
Selye H (1939) The effect of adaptation to various damaging agents on the female sex organs 
in the rat. Endocrinology 25:615. 
Selye H (1946) The general adaptation syndrome and the diseases of adaptation. J Clin 
Endocrinol Metab 6:117-230. 
Selye H (1975) Confusion and controversy in the stress field. J Human Stress 1:37-44. 
Selye H (1976) The stress of life. New York: McGraw-Hill. 
Sheridan JF, Stark JL, Avitsur R, Padgett DA (2000) Social disruption, immunity, and 
susceptibility to viral infection. Role of glucocorticoid insensitivity and NGF. Ann N 
Y Acad Sci 917:894-905. 
Sherman AD, Gubhart GF (1974) Regional levels of GABA and glutamate in mouse brain 
following exposure to pain. Neuropharmacology 13:673-675. 
98 
 
Sherwood A, Hughes JW, Kuhn C, Hinderliter AL (2004) Hostility is related to blunted 
beta-adrenergic receptor responsiveness among middle-aged women. Psychosom Med 
66:507-513. 
Smets LA, Salomons G, van den Berg J (1999) Glucocorticoid induced apoptosis in 
leukemia. Adv Exp Med Biol 457:607-614. 
Smith C, Myburgh KH (2004) Treatment with Sutherlandia frutescens spp. microphilla 
alters the corticosterone response to chronic intermittent immobilization stress in rats. 
South African Journal of Science 100:229-232. 
Smith C, Wilson NW, Louw A, Myburgh KH (2007) Illuminating the interrelated immune 
and endocrine adaptations after multiple exposures to short immobilization stress by 
in vivo blocking of IL-6. Am J Physiol Regul Integr Comp Physiol 292:R1439-1447. 
Song DK, Suh HW, Huh SO, Jung JS, Ihn BM, Choi IG, Kim YH (1998) Central 
GABAA and GABAB receptor modulation of basal and stress-induced plasma 
interleukin-6 levels in mice. J Pharmacol Exp Ther 287:144-149. 
Spinedi E, Hadid R, Daneva T, Gaillard RC (1992) Cytokines stimulate the CRH but not 
the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 
action. Neuroendocrinology 56:46-53. 
Stafford GI, Pedersen ME, van Staden J, Jager AK (2008) Review on plants with CNS-
effects used in traditional South African medicine against mental diseases. Journal of 
ethnopharmacology 119:513-537. 
Steptoe A, Willemsen G, Owen N, Flower L, Mohamed-Ali V (2001) Acute mental stress 
elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci (Lond) 
101:185-192. 
Swerdloff RS, Wang C, Hines M, Gorski R (1992) Effect of androgens on the brain and 
other organs during development and aging. Psychoneuroendocrinology 17:375-383. 
Tai J, Cheung S, Chan E, Hasman D (2004) In vitro culture studies of Sutherlandia 
frutescens on human tumor cell lines. J Ethnopharmacol 93:9-19. 
99 
 
Taylor SE, Klein LC, Lewis BP, Gruenewald TL, Gurung RA, Updegraff JA (2000) 
Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. 
Psychol Rev 107:411-429. 
Tilbrook AJ, Canny BJ, Serapiglia MD, Ambrose TJ, Clarke IJ (1999) Suppression of 
the secretion of luteinizing hormone due to isolation/restraint stress in 
gonadectomised rams and ewes is influenced by sex steroids. J Endocrinol 160:469-
481. 
Tisch S, Silberstein P, Limousin-Dowsey P, Jahanshahi M (2004) The basal ganglia: 
anatomy, physiology, and pharmacology. Psychiatr Clin North Am 27:757-799. 
Toth IE, Banczerowski P, Boldogkoi Z, Toth JS, Szabo A, Halasz B, Gerendai I (2008a) 
Cerebral neurons involved in the innervation of both the adrenal gland and the ovary: 
A double viral tracing study. Brain Res Bull. 
Toth IE, Wiesel O, Toth DE, Boldogkoi Z, Halasz B, Gerendai I (2008b) Transneuronal 
retrograde viral labeling in the brain stem and hypothalamus is more intense from the 
left than from the right adrenal gland. Microsc Res Tech 71:503-509. 
Turnbull AV, Rivier C (1995) Regulation of the HPA axis by cytokines. Brain Behav 
Immun 9:253-275. 
Uchino BN, Cacioppo JT, Malarkey W, Glaser R (1995) Individual differences in cardiac 
sympathetic control predict endocrine and immune responses to acute psychological 
stress. J Pers Soc Psychol 69:736-743. 
Uchiyama Y, Yoshida H, Koike N, Hayakawa N, Sugita A, Nishimura T, Mihara M 
(2008) Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-
6 clearance, but not via the induction of IL-6 production. Int Immunopharmacol 
8:1595-1601. 
Uhart M, McCaul ME, Oswald LM, Choi L, Wand GS (2004) GABRA6 gene 
polymorphism and an attenuated stress response. Mol Psychiatry 9:998-1006. 
Unsicker K (1971) Innervation of mammalian endocrine glands (anterior pituitary and 
parathyroids). Z Zellforsch Mikrosk Anat 121:283-291. 
100 
 
Vaccarino V, Johnson BD, Sheps DS, Reis SE, Kelsey SF, Bittner V, Rutledge T, Shaw 
LJ, Sopko G, Bairey Merz CN (2007) Depression, inflammation, and incident 
cardiovascular disease in women with suspected coronary ischemia: the National 
Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol 50:2044-
2050. 
van Wyk B-E, Albrecht C (2008) A review of the taxonomy, ethnobotany, chemistry and 
pharmacology of Sutherlandia frutescens (Fabaceae). Journal of ethnopharmacology 
119:620-629. 
Viljoen PT (1969) The oxidation of pinitol and partial identification of a triterpene glycoside 
from Sutherlandia microphylla. vol. M.Sc  Bloemfontein: University of Free State. 
von Euler US (1967) Adrenal medullary secretion and its neural control. In: 
Neuroendocrinology, vol. 2 (Martini, L. and Ganong, W. F., eds), pp 283-322 NY: 
Academic Press. 
Walters RJ (2004) Excitation and adrenaline: GABA—the bipolar neurotransmitter. 
Cellscience reviews 82. 
Ward LD, Howlett GJ, Discolo G, Yasukawa K, Hammacher A, Moritz RL, Simpson 
RJ (1994) High affinity interleukin-6 receptor is a hexameric complex consisting of 
two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem 
269:23286-23289. 
Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid 
signaling in the hippocampus. Neuron 31:453-462. 
Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at 
hippocampal synapses. Nature 410:588-592. 
Wurtman RJ (1966) Control of epinephrine synthesis by the pituitary and adrenal cortex: 
possible role in the pathophysiology of chronic stress. Recent Adv Biol Psychiatry 
9:359-368. 
101 
 
Xia Y, Hu HZ, Liu S, Ren J, Zafirov DH, Wood JD (1999) IL-1beta and IL-6 excite 
neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig 
enteric nervous system. J Clin Invest 103:1309-1316. 
Yoneda Y, Kanmori K, Ida S, Kuriyama K (1983) Stress-induced alterations in 
metabolism of gamma-aminobutyric acid in rat brain. J Neurochem 40:350-356. 
Yusuf S, Reddy S, Ounpuu S, Anand A (2001) Global burden of cardiovascular diseases: 
part I: general considerations, the epidemiologic transition, risk factors, and impact of 
urbanization. Circulation 104:2746-2753. 
Zhang MY, Hashimoto T, Kuriyama K (1990) Stress induced alterations in striatal 
GABAA receptor complex. Jpn J Pharmacol 53:121-124. 
Zhe D, Fang H, Yuxiu S (2008) Expressions of hippocampal mineralocorticoid receptor 
(MR) and glucocorticoid receptor (GR) in the single-prolonged stress-rats. Acta 
Histochem Cytochem 41:89-95. 
Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS (1993) Exposure to physical 
and psychological stressors elevates plasma interleukin 6: relationship to the 
activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133:2523-2530. 
 
 
 
 
 
 
 
 
 
 
102 
 
Appendix A 
Cytokine Bio-plex multiplex bead-based assay  
To determine the plasma cytokine concentrations, a commercially available bead-based 
system, obtained from Biorad Laboratories Inc. (Parklands, South Africa), was used. This kit 
system comprised the following components: 
• 171-K11070 - Multiplex kit, including cytokine antibody-coupled beads (specific for 
cytokines specified by user), detection antibodies and standards  
• 171-305008 - Serum diluent specific for rat samples 
• 171-203001 - Reagent kit, including 96-well filter plate, assay buffer, wash buffer, 
detection antibody diluent, PE-labelled streptavidin and sealing tape. 
NOTE: In order to maintain the Bioplex instrument, regular calibration and validation of day-
to-day reproducibility was performed by a laboratory technician (using calibration kit with 
catalogue number 171-000201 and validation kit with catalogue # 171-203060).    
Procedure: 
1. Pre-wet filter plate with 100 µl of Bio-Plex assay buffer.  
2. Vortex multiplex bead solution and add 50 µl into each well. 
3. Wash twice with 100 µl wash buffer (remove buffer by vacuum filtration). 
4. Add 50 µl standards, controls and samples (prepared according to manufacturers’ 
instructions) into designated wells, cover with sealing tape and aluminium foil and 
incubate on microplate shaker at 300 rpm for 30 min at RT. 
5. Wash three times with wash buffer. 
6. Add 25 µl detection antibody (prepared according to manufacturers’ instructions), cover 
and incubate on microplate shaker at 300 rpm for 30 min at RT. 
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7. Wash three times with wash buffer. 
8. Add 50 µl strepdavidin-PE, cover and incubate on microplate shaker at 300 rpm for 10 
min at RT. 
9. Wash three times with wash buffer. 
10. Resuspend the beads in each well with 125 µl of Bio-Plex assay buffer and read 
immediately on Bio-Plex system. 
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Appendix B 
Enzyme immuno assay (EIA) 
Plasma corticosterone (AC-14F1, Immunodiagnostic systems), ACTH (7023, Biomerica) and 
testosterone (EIA-1559 DRG Diagnostics) was assayed according to the manufacturer’s 
instructions. Asays were carried out using 96-well micro titre plates coated with either a 
polyclonal rabbit anti-corticosterone antibody or a mouse monoclonal anti-testosterone 
antibody. All reagents, including antibody reagents, used was supplied with the kit.  
Procedure:  
1. Add 100 µl standards, controls (non-serum, provided in kit) and samples in duplicate in 
the appropriate wells. 
2. Add 100 µl enzyme conjugate solution in each well and mix. For the corticosterone assay.  
The solution contained either HRP labelled corticosterone or testosterone. Incubate for 1 
hr at RT. 
3. Shake out the contents and wash three times with 400 µl PBS-Tween. Blot dry on 
absorbant tissue. 
4. Add 200 µl substrate solution TMB)/H2O2 and incubate 30 min at RT. 
5. Add 100 µl stop solution (0,5M HCl or 0.5M H2SO4) to all wells. 
6. Measure absorbance at 450 nm within 30 min. 
Prepare the standard curve and determine the sample concentrations 
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Appendix C 
Immunohistochemistry (IHC) using fluorescence 
Co-staining were performed using primary antibodies directed against GABAARα1 and GR 
with Texas Red and FITC secondaries used respectively for visualisation. Specific antibodies 
used in the current experiment included: 
a) GABAARα1 assay.  Prim Ab, 1:1000 (sc-31404, Santa Cruz Biotechnology Inc.); sec 
Ab, 1:1000 (sc-2090, Santa Cruz Biotechnology Inc.). 
b) GR assay.  Prim Ab, 1:1000 (sc-8992, Santa Cruz Biotechnology Inc.); sec Ab, 
1:1000 (sc-2783, Santa Cruz Biotechnology Inc.). 
Procedure: 
1. Fix frozen sections in 2% paraformaldehyde for 10 min at RT. 
2.  Wash slides in 0.1 M PBS. 
3. Encircle samples with a wax pen. 
4.  Block for 30 min in 5% serum at RT. (Note: use the same serum in which the secondary 
antibody is raised) 
5.  Shake off serum and incubate sections for 4 hr at RT or overnight at 4°C with the 1st 
primary antibody.  (Note:  Do not wash after serum blocking step) 
6.  Wash slides with PBS and add the secondary antibody to the sections.  Incubate for 1 hr at 
RT. (donkey anti-goat in the case of GABAARα1 and donkey anti-rabbit in the case of GR).  
(Note:  the secondary antibody is fluorescently labelled, so from this step forward, all steps 
should be performed in the dark) 
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7.  Wash slides with PBS and add the 2nd primary antibody overnight at 4°C or for 4 hrs at 
RT, depending on the 1st primary. 
8.  Add the secondary antibody for 1 hr after washing the sections thoroughly with PBS. 
9.  Wash sections and add Hoechst (1/8000) for 15 min. 
10. Wash slides well and mount with DAKO fluorescent mounting medium (Dako, 
Diagnostech, Glostrup, Denmark). 
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Appendix D 
Immunohistochemistry (IHC) using ABC method 
• All steps are carried out at RT in a humidified chamber. 
• Slides are placed horizontally for staining. Ensure application of sufficient volumes of 
reagents to completely cover the sections; 100 µl is usually adequate, or 1-3 drops of 
working solutions.  Use filter paper to remove reagents after each step but avoid 
drying of samples between steps. 
Antibodies used included: 
a) IL-6 assay.  Prim Ab, 1:800 (sc-1265, Santa Cruz Biotechnology Inc.); sec Ab, 1:800 
(sc-2023, Santa Cruz Biotechnology Inc.). 
b) ACTH assay.  Prim Ab, 1:800 (NB 600-1367, Novus Biologicals); sec Ab, 1:800 (sc-
2017, Santa Cruz Biotechnology Inc.) 
 
Deparaffinise and dehydrate paraffin embedded tissue prior to immunohistochemistry 
Incubate sections in xylene for 2 changes of 5 min each, 100 % absolute alcohol for 2 
changes of 3 min each,  95 % alcohol for 2 changes of 3 min each, 80 % alcohol for 3 min, 50 
% alcohol for 3 min,  and then in distilled water for 2 changes, 3 min each. 
Procedure: 
1. Incubate slides for 5-10 min in 1% H2O2 diluted in 0.1 M PBS to quench endogenous 
peroxidase activity and wash slides twice with PBS. 
2. Reduce non-specific (background) staining by blocking for 1 hr in 1.5% serum in 
PBS.   
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3. Incubate with primary antibody for 30 min at RT or overnight at 4º C.  (Optimal 
concentration should be determined for each experiment by titration; recommended 
range is 0.5-5.0 µg/ml, diluted in1.5% blocking serum). 
4. Wash three times with 0.1 M PBS. 
5. Incubate sections for 30 min with biotinylated secondary antibody at approximately 1 
µg/ml and wash three times with PBS. 
6. Incubate sections for 30 min with AB enzyme reagent and wash three times with 0.1 
M PBS. 
7. Incubate sections in 1-3 drops peroxidase substrate for 3 sec – 10 min or until desired 
stain intensity develops.  The section may be checked for staining by rinsing with 
H2O and viewing under a microscope.  If necessary, add additional peroxidase 
substrate and continue to incubate. Standardise this incubation time for each 
experiment once optimized. 
8. Wash five times with deionised H2O. 
9. Counterstain with Gill’s formulation #2 hematoxylin for 5-10 sec and wash with 
deionised H2O. 
10. Destain with 1% acid alcohol (10 ml 1 % HCl dissolved in 1 ℓ 70 % alcohol) and 
bluing reagent (supplied in kit) and wash with tap water. 
11. Dehydrate by dipping slides 2X in 95% ethanol for 10 sec each, 2X in 100% ethanol 
for 10 sec each and 3X in xylene for 10 sec each 
12. Immediately add 1-2 drops of permanent mounting medium and cover with glass 
coverslip. 
 
 
 
